Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Yellow nail syndrome: a review

Identifieur interne : 000F64 ( Pmc/Corpus ); précédent : 000F63; suivant : 000F65

Yellow nail syndrome: a review

Auteurs : Stéphane Vignes ; Robert Baran

Source :

RBID : PMC:5327582

Abstract

Yellow nail syndrome (YNS; OMIM 153300, ORPHA662) is a very rare disorder that almost always occurs after 50 years of age but a juvenile or familial form has also been observed. YNS is diagnosed based on a triad associating yellow nail discoloration, pulmonary manifestations (chronic cough, bronchiectasia, pleural effusion) and lower limb lymphedema. Chronic sinusitis is frequently associated with the triad. YNS etiology remains unknown but a role of lymphatic impairment is usually evoked. YNS is more frequently isolated but may be associated in rare cases with autoimmune diseases, other clinical manifestations implicating lymphatic functions or cancer and, hence, is also considered a paraneoplastic syndrome. YNS management is symptomatic and not codified. YNS can resolve spontaneously. Oral vitamin E alone or even better when associated with triazole antifungals may achieve partial or total disappearance of nail discoloration. Pleural effusion can be treated surgically, with decortication/pleurectomy or pleurodesis. Antibiotic prophylaxis is prescribed for bronchiectasia with chronic sputum production. Lymphedema treatment is based on low-stretch bandages and the wearing of elastic compression garments combined with skin care, exercises and, as needed, manual lymph drainage.


Url:
DOI: 10.1186/s13023-017-0594-4
PubMed: 28241848
PubMed Central: 5327582

Links to Exploration step

PMC:5327582

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Yellow nail syndrome: a review</title>
<author>
<name sortKey="Vignes, Stephane" sort="Vignes, Stephane" uniqKey="Vignes S" first="Stéphane" last="Vignes">Stéphane Vignes</name>
<affiliation>
<nlm:aff id="Aff1">Department of Lymphology, Centre National de Référence des Maladies Vasculaires Rares (Lymphœdèmes primaires), Hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Baran, Robert" sort="Baran, Robert" uniqKey="Baran R" first="Robert" last="Baran">Robert Baran</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2188 3779</institution-id>
<institution-id institution-id-type="GRID">grid.7459.f</institution-id>
<institution></institution>
<institution>Nail Disease Centre,</institution>
</institution-wrap>
42, rue des Serbes, 06400 Cannes, France</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">28241848</idno>
<idno type="pmc">5327582</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327582</idno>
<idno type="RBID">PMC:5327582</idno>
<idno type="doi">10.1186/s13023-017-0594-4</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000F64</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000F64</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Yellow nail syndrome: a review</title>
<author>
<name sortKey="Vignes, Stephane" sort="Vignes, Stephane" uniqKey="Vignes S" first="Stéphane" last="Vignes">Stéphane Vignes</name>
<affiliation>
<nlm:aff id="Aff1">Department of Lymphology, Centre National de Référence des Maladies Vasculaires Rares (Lymphœdèmes primaires), Hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Baran, Robert" sort="Baran, Robert" uniqKey="Baran R" first="Robert" last="Baran">Robert Baran</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2188 3779</institution-id>
<institution-id institution-id-type="GRID">grid.7459.f</institution-id>
<institution></institution>
<institution>Nail Disease Centre,</institution>
</institution-wrap>
42, rue des Serbes, 06400 Cannes, France</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Orphanet Journal of Rare Diseases</title>
<idno type="eISSN">1750-1172</idno>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Yellow nail syndrome (YNS; OMIM 153300, ORPHA662) is a very rare disorder that almost always occurs after 50 years of age but a juvenile or familial form has also been observed. YNS is diagnosed based on a triad associating yellow nail discoloration, pulmonary manifestations (chronic cough, bronchiectasia, pleural effusion) and lower limb lymphedema. Chronic sinusitis is frequently associated with the triad. YNS etiology remains unknown but a role of lymphatic impairment is usually evoked. YNS is more frequently isolated but may be associated in rare cases with autoimmune diseases, other clinical manifestations implicating lymphatic functions or cancer and, hence, is also considered a paraneoplastic syndrome. YNS management is symptomatic and not codified. YNS can resolve spontaneously. Oral vitamin E alone or even better when associated with triazole antifungals may achieve partial or total disappearance of nail discoloration. Pleural effusion can be treated surgically, with decortication/pleurectomy or pleurodesis. Antibiotic prophylaxis is prescribed for bronchiectasia with chronic sputum production. Lymphedema treatment is based on low-stretch bandages and the wearing of elastic compression garments combined with skin care, exercises and, as needed, manual lymph drainage.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Heller, J" uniqKey="Heller J">J Heller</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Samman, Pd" uniqKey="Samman P">PD Samman</name>
</author>
<author>
<name sortKey="White, Wf" uniqKey="White W">WF White</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Emerson, Pa" uniqKey="Emerson P">PA Emerson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hiller, E" uniqKey="Hiller E">E Hiller</name>
</author>
<author>
<name sortKey="Rosenow, Ec" uniqKey="Rosenow E">EC Rosenow</name>
</author>
<author>
<name sortKey="Olsen, Am" uniqKey="Olsen A">AM Olsen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hoque, Sr" uniqKey="Hoque S">SR Hoque</name>
</author>
<author>
<name sortKey="Mansour, S" uniqKey="Mansour S">S Mansour</name>
</author>
<author>
<name sortKey="Mortimer, Ps" uniqKey="Mortimer P">PS Mortimer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Maldonado, F" uniqKey="Maldonado F">F Maldonado</name>
</author>
<author>
<name sortKey="Tazelaar, Hd" uniqKey="Tazelaar H">HD Tazelaar</name>
</author>
<author>
<name sortKey="Wang, Cw" uniqKey="Wang C">CW Wang</name>
</author>
<author>
<name sortKey="Ryu, Jh" uniqKey="Ryu J">JH Ryu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Piraccini, Bm" uniqKey="Piraccini B">BM Piraccini</name>
</author>
<author>
<name sortKey="Urciuoli, B" uniqKey="Urciuoli B">B Urciuoli</name>
</author>
<author>
<name sortKey="Starace, M" uniqKey="Starace M">M Starace</name>
</author>
<author>
<name sortKey="Tosti, A" uniqKey="Tosti A">A Tosti</name>
</author>
<author>
<name sortKey="Balestri, R" uniqKey="Balestri R">R Balestri</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nordkild, P" uniqKey="Nordkild P">P Nordkild</name>
</author>
<author>
<name sortKey="Kromann Andersen, H" uniqKey="Kromann Andersen H">H Kromann-Andersen</name>
</author>
<author>
<name sortKey="Struve Christensen, E" uniqKey="Struve Christensen E">E Struve-Christensen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Varney, Va" uniqKey="Varney V">VA Varney</name>
</author>
<author>
<name sortKey="Cumberworth, V" uniqKey="Cumberworth V">V Cumberworth</name>
</author>
<author>
<name sortKey="Sudderick, R" uniqKey="Sudderick R">R Sudderick</name>
</author>
<author>
<name sortKey="Durham, Sr" uniqKey="Durham S">SR Durham</name>
</author>
<author>
<name sortKey="Mackay, Is" uniqKey="Mackay I">IS Mackay</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pavlidakey, Gp" uniqKey="Pavlidakey G">GP Pavlidakey</name>
</author>
<author>
<name sortKey="Hashimoto, K" uniqKey="Hashimoto K">K Hashimoto</name>
</author>
<author>
<name sortKey="Blum, D" uniqKey="Blum D">D Blum</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Magid, M" uniqKey="Magid M">M Magid</name>
</author>
<author>
<name sortKey="Esterly, Nb" uniqKey="Esterly N">NB Esterly</name>
</author>
<author>
<name sortKey="Prendiville, J" uniqKey="Prendiville J">J Prendiville</name>
</author>
<author>
<name sortKey="Fujisaki, C" uniqKey="Fujisaki C">C Fujisaki</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Paradisis, M" uniqKey="Paradisis M">M Paradisis</name>
</author>
<author>
<name sortKey="Van Asperen, P" uniqKey="Van Asperen P">P Van Asperen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gocmen, A" uniqKey="Gocmen A">A Göçmen</name>
</author>
<author>
<name sortKey="Kucukosmanoglu, O" uniqKey="Kucukosmanoglu O">O Küçükosmanoglu</name>
</author>
<author>
<name sortKey="Kiper, N" uniqKey="Kiper N">N Kiper</name>
</author>
<author>
<name sortKey="Karaduman, A" uniqKey="Karaduman A">A Karaduman</name>
</author>
<author>
<name sortKey="Ozcelik, U" uniqKey="Ozcelik U">U Ozçelik</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yalcin, E" uniqKey="Yalcin E">E Yalçin</name>
</author>
<author>
<name sortKey="Dogru, D" uniqKey="Dogru D">D Dogru</name>
</author>
<author>
<name sortKey="Gonc, En" uniqKey="Gonc E">EN Gönç</name>
</author>
<author>
<name sortKey="Cetinkaya, A" uniqKey="Cetinkaya A">A Cetinkaya</name>
</author>
<author>
<name sortKey="Kiper, N" uniqKey="Kiper N">N Kiper</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Douri, T" uniqKey="Douri T">T Douri</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cebeci, F" uniqKey="Cebeci F">F Cebeci</name>
</author>
<author>
<name sortKey="Celebi, M" uniqKey="Celebi M">M Celebi</name>
</author>
<author>
<name sortKey="Onsun, N" uniqKey="Onsun N">N Onsun</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nanda, A" uniqKey="Nanda A">A Nanda</name>
</author>
<author>
<name sortKey="Al Essa, Fh" uniqKey="Al Essa F">FH Al-Essa</name>
</author>
<author>
<name sortKey="El Shafei, Wm" uniqKey="El Shafei W">WM El-Shafei</name>
</author>
<author>
<name sortKey="Alsaleh, Qa" uniqKey="Alsaleh Q">QA Alsaleh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Siddiq, I" uniqKey="Siddiq I">I Siddiq</name>
</author>
<author>
<name sortKey="Hughes, Dm" uniqKey="Hughes D">DM Hughes</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cecchini, M" uniqKey="Cecchini M">M Cecchini</name>
</author>
<author>
<name sortKey="Doumit, J" uniqKey="Doumit J">J Doumit</name>
</author>
<author>
<name sortKey="Kanigsberg, N" uniqKey="Kanigsberg N">N Kanigsberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dessart, P" uniqKey="Dessart P">P Dessart</name>
</author>
<author>
<name sortKey="Deries, X" uniqKey="Deries X">X Deries</name>
</author>
<author>
<name sortKey="Guerin Moreau, M" uniqKey="Guerin Moreau M">M Guérin-Moreau</name>
</author>
<author>
<name sortKey="Troussier, F" uniqKey="Troussier F">F Troussier</name>
</author>
<author>
<name sortKey="Martin, L" uniqKey="Martin L">L Martin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Al Hawsawi, K" uniqKey="Al Hawsawi K">K Al Hawsawi</name>
</author>
<author>
<name sortKey="Pope, E" uniqKey="Pope E">E Pope</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wells, Gc" uniqKey="Wells G">GC Wells</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lambert, Em" uniqKey="Lambert E">EM Lambert</name>
</author>
<author>
<name sortKey="Dziura, J" uniqKey="Dziura J">J Dziura</name>
</author>
<author>
<name sortKey="Kauls, L" uniqKey="Kauls L">L Kauls</name>
</author>
<author>
<name sortKey="Mercurio, M" uniqKey="Mercurio M">M Mercurio</name>
</author>
<author>
<name sortKey="Antaya, Rj" uniqKey="Antaya R">RJ Antaya</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Razi, E" uniqKey="Razi E">E Razi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kamatani, M" uniqKey="Kamatani M">M Kamatani</name>
</author>
<author>
<name sortKey="Rai, A" uniqKey="Rai A">A Rai</name>
</author>
<author>
<name sortKey="Hen, H" uniqKey="Hen H">H Hen</name>
</author>
<author>
<name sortKey="Hayashi, K" uniqKey="Hayashi K">K Hayashi</name>
</author>
<author>
<name sortKey="Aoki, T" uniqKey="Aoki T">T Aoki</name>
</author>
<author>
<name sortKey="Umeyama, K" uniqKey="Umeyama K">K Umeyama</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kleinman, Pk" uniqKey="Kleinman P">PK Kleinman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baran, R" uniqKey="Baran R">R Baran</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stosiek, N" uniqKey="Stosiek N">N Stosiek</name>
</author>
<author>
<name sortKey="Peters, Kp" uniqKey="Peters K">KP Peters</name>
</author>
<author>
<name sortKey="Hiller, D" uniqKey="Hiller D">D Hiller</name>
</author>
<author>
<name sortKey="Riedl, B" uniqKey="Riedl B">B Riedl</name>
</author>
<author>
<name sortKey="Hornstein, Op" uniqKey="Hornstein O">OP Hornstein</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Holzberg, M" uniqKey="Holzberg M">M Holzberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Venencie, Py" uniqKey="Venencie P">PY Venencie</name>
</author>
<author>
<name sortKey="Dicken, Ch" uniqKey="Dicken C">CH Dicken</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Moffitt, Dl" uniqKey="Moffitt D">DL Moffitt</name>
</author>
<author>
<name sortKey="De Berker, Da" uniqKey="De Berker D">DA de Berker</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Valdes, L" uniqKey="Valdes L">L Valdés</name>
</author>
<author>
<name sortKey="Huggins, Jt" uniqKey="Huggins J">JT Huggins</name>
</author>
<author>
<name sortKey="Gude, F" uniqKey="Gude F">F Gude</name>
</author>
<author>
<name sortKey="Ferreiro, L" uniqKey="Ferreiro L">L Ferreiro</name>
</author>
<author>
<name sortKey="Alvarez Doba O, Jm" uniqKey="Alvarez Doba O J">JM Alvarez-Dobaño</name>
</author>
<author>
<name sortKey="Golpe, A" uniqKey="Golpe A">A Golpe</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Woodfield, G" uniqKey="Woodfield G">G Woodfield</name>
</author>
<author>
<name sortKey="Nisbet, M" uniqKey="Nisbet M">M Nisbet</name>
</author>
<author>
<name sortKey="Jacob, J" uniqKey="Jacob J">J Jacob</name>
</author>
<author>
<name sortKey="Mok, W" uniqKey="Mok W">W Mok</name>
</author>
<author>
<name sortKey="Loebinger, Mr" uniqKey="Loebinger M">MR Loebinger</name>
</author>
<author>
<name sortKey="Hansell, Dm" uniqKey="Hansell D">DM Hansell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sacco, O" uniqKey="Sacco O">O Sacco</name>
</author>
<author>
<name sortKey="Fregonese, B" uniqKey="Fregonese B">B Fregonese</name>
</author>
<author>
<name sortKey="Marino, Ce" uniqKey="Marino C">CE Marino</name>
</author>
<author>
<name sortKey="Mattioli, G" uniqKey="Mattioli G">G Mattioli</name>
</author>
<author>
<name sortKey="Gambini, C" uniqKey="Gambini C">C Gambini</name>
</author>
<author>
<name sortKey="Rossi, Ga" uniqKey="Rossi G">GA Rossi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Szuba, A" uniqKey="Szuba A">A Szuba</name>
</author>
<author>
<name sortKey="Rockson, Sg" uniqKey="Rockson S">SG Rockson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zampell, Jc" uniqKey="Zampell J">JC Zampell</name>
</author>
<author>
<name sortKey="Aschen, S" uniqKey="Aschen S">S Aschen</name>
</author>
<author>
<name sortKey="Weitman, Es" uniqKey="Weitman E">ES Weitman</name>
</author>
<author>
<name sortKey="Yan, A" uniqKey="Yan A">A Yan</name>
</author>
<author>
<name sortKey="Elhadad, S" uniqKey="Elhadad S">S Elhadad</name>
</author>
<author>
<name sortKey="De Brot, M" uniqKey="De Brot M">M De Brot</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dupuy, A" uniqKey="Dupuy A">A Dupuy</name>
</author>
<author>
<name sortKey="Benchikhi, H" uniqKey="Benchikhi H">H Benchikhi</name>
</author>
<author>
<name sortKey="Roujeau, Jc" uniqKey="Roujeau J">JC Roujeau</name>
</author>
<author>
<name sortKey="Bernard, P" uniqKey="Bernard P">P Bernard</name>
</author>
<author>
<name sortKey="Vaillant, L" uniqKey="Vaillant L">L Vaillant</name>
</author>
<author>
<name sortKey="Chosidow, O" uniqKey="Chosidow O">O Chosidow</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Okajima, S" uniqKey="Okajima S">S Okajima</name>
</author>
<author>
<name sortKey="Hirota, A" uniqKey="Hirota A">A Hirota</name>
</author>
<author>
<name sortKey="Kimura, E" uniqKey="Kimura E">E Kimura</name>
</author>
<author>
<name sortKey="Inagaki, M" uniqKey="Inagaki M">M Inagaki</name>
</author>
<author>
<name sortKey="Tamai, N" uniqKey="Tamai N">N Tamai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Maisels, Do" uniqKey="Maisels D">DO Maisels</name>
</author>
<author>
<name sortKey="Korachi, Ao" uniqKey="Korachi A">AO Korachi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bourcier, T" uniqKey="Bourcier T">T Bourcier</name>
</author>
<author>
<name sortKey="Baudrimont, M" uniqKey="Baudrimont M">M Baudrimont</name>
</author>
<author>
<name sortKey="Borderie, V" uniqKey="Borderie V">V Borderie</name>
</author>
<author>
<name sortKey="Mayaud, C" uniqKey="Mayaud C">C Mayaud</name>
</author>
<author>
<name sortKey="Laroche, L" uniqKey="Laroche L">L Laroche</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Marks, R" uniqKey="Marks R">R Marks</name>
</author>
<author>
<name sortKey="Ellis, Jp" uniqKey="Ellis J">JP Ellis</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bull, Rh" uniqKey="Bull R">RH Bull</name>
</author>
<author>
<name sortKey="Fenton, Da" uniqKey="Fenton D">DA Fenton</name>
</author>
<author>
<name sortKey="Mortimer, Ps" uniqKey="Mortimer P">PS Mortimer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Maldonado, F" uniqKey="Maldonado F">F Maldonado</name>
</author>
<author>
<name sortKey="Ryu, Jh" uniqKey="Ryu J">JH Ryu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="D Lessandro, A" uniqKey="D Lessandro A">A D’Alessandro</name>
</author>
<author>
<name sortKey="Muzi, G" uniqKey="Muzi G">G Muzi</name>
</author>
<author>
<name sortKey="Monaco, A" uniqKey="Monaco A">A Monaco</name>
</author>
<author>
<name sortKey="Filiberto, S" uniqKey="Filiberto S">S Filiberto</name>
</author>
<author>
<name sortKey="Barboni, A" uniqKey="Barboni A">A Barboni</name>
</author>
<author>
<name sortKey="Abbritti, G" uniqKey="Abbritti G">G Abbritti</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Decoste, Sd" uniqKey="Decoste S">SD DeCoste</name>
</author>
<author>
<name sortKey="Imber, Mj" uniqKey="Imber M">MJ Imber</name>
</author>
<author>
<name sortKey="Baden, Hp" uniqKey="Baden H">HP Baden</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Solal Celigny, P" uniqKey="Solal Celigny P">P Solal-Céligny</name>
</author>
<author>
<name sortKey="Cormier, Y" uniqKey="Cormier Y">Y Cormier</name>
</author>
<author>
<name sortKey="Fournier, M" uniqKey="Fournier M">M Fournier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Brooks, Kg" uniqKey="Brooks K">KG Brooks</name>
</author>
<author>
<name sortKey="Echevarria, C" uniqKey="Echevarria C">C Echevarria</name>
</author>
<author>
<name sortKey="Cooper, D" uniqKey="Cooper D">D Cooper</name>
</author>
<author>
<name sortKey="Bourke, Sc" uniqKey="Bourke S">SC Bourke</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Norton, L" uniqKey="Norton L">L Norton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Berglund, F" uniqKey="Berglund F">F Berglund</name>
</author>
<author>
<name sortKey="Carlmark, B" uniqKey="Carlmark B">B Carlmark</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Decker, A" uniqKey="Decker A">A Decker</name>
</author>
<author>
<name sortKey="Daly, D" uniqKey="Daly D">D Daly</name>
</author>
<author>
<name sortKey="Scher, Rk" uniqKey="Scher R">RK Scher</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ataya, A" uniqKey="Ataya A">A Ataya</name>
</author>
<author>
<name sortKey="Kline, Kp" uniqKey="Kline K">KP Kline</name>
</author>
<author>
<name sortKey="Cope, J" uniqKey="Cope J">J Cope</name>
</author>
<author>
<name sortKey="Alnuaimat, H" uniqKey="Alnuaimat H">H Alnuaimat</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hsu, Ty" uniqKey="Hsu T">TY Hsu</name>
</author>
<author>
<name sortKey="Lin, Cc" uniqKey="Lin C">CC Lin</name>
</author>
<author>
<name sortKey="Lee, Md" uniqKey="Lee M">MD Lee</name>
</author>
<author>
<name sortKey="Chang, Bp" uniqKey="Chang B">BP Chang</name>
</author>
<author>
<name sortKey="Tsai, Jd" uniqKey="Tsai J">JD Tsai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dos Santos, Vm" uniqKey="Dos Santos V">VM Dos Santos</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Slee, J" uniqKey="Slee J">J Slee</name>
</author>
<author>
<name sortKey="Nelson, J" uniqKey="Nelson J">J Nelson</name>
</author>
<author>
<name sortKey="Dickinson, J" uniqKey="Dickinson J">J Dickinson</name>
</author>
<author>
<name sortKey="Kendall, P" uniqKey="Kendall P">P Kendall</name>
</author>
<author>
<name sortKey="Halbert, A" uniqKey="Halbert A">A Halbert</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Govaert, P" uniqKey="Govaert P">P Govaert</name>
</author>
<author>
<name sortKey="Leroy, Jg" uniqKey="Leroy J">JG Leroy</name>
</author>
<author>
<name sortKey="Pauwels, R" uniqKey="Pauwels R">R Pauwels</name>
</author>
<author>
<name sortKey="Vanhaesebrouck, P" uniqKey="Vanhaesebrouck P">P Vanhaesebrouck</name>
</author>
<author>
<name sortKey="De Praeter, C" uniqKey="De Praeter C">C De Praeter</name>
</author>
<author>
<name sortKey="Van Kets, H" uniqKey="Van Kets H">H Van Kets</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Desrame, J" uniqKey="Desrame J">J Desramé</name>
</author>
<author>
<name sortKey="Bechade, D" uniqKey="Bechade D">D Béchade</name>
</author>
<author>
<name sortKey="Patte, Jh" uniqKey="Patte J">JH Patte</name>
</author>
<author>
<name sortKey="Jean, R" uniqKey="Jean R">R Jean</name>
</author>
<author>
<name sortKey="Karsenti, D" uniqKey="Karsenti D">D Karsenti</name>
</author>
<author>
<name sortKey="Coutant, G" uniqKey="Coutant G">G Coutant</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Duhra, Pm" uniqKey="Duhra P">PM Duhra</name>
</author>
<author>
<name sortKey="Quigley, Em" uniqKey="Quigley E">EM Quigley</name>
</author>
<author>
<name sortKey="Marsh, Mn" uniqKey="Marsh M">MN Marsh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vignes, S" uniqKey="Vignes S">S Vignes</name>
</author>
<author>
<name sortKey="Bellanger, J" uniqKey="Bellanger J">J Bellanger</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Brice, G" uniqKey="Brice G">G Brice</name>
</author>
<author>
<name sortKey="Mansour, S" uniqKey="Mansour S">S Mansour</name>
</author>
<author>
<name sortKey="Bell, R" uniqKey="Bell R">R Bell</name>
</author>
<author>
<name sortKey="Collin, Jr" uniqKey="Collin J">JR Collin</name>
</author>
<author>
<name sortKey="Child, Ah" uniqKey="Child A">AH Child</name>
</author>
<author>
<name sortKey="Brady, Af" uniqKey="Brady A">AF Brady</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Thomas, Ps" uniqKey="Thomas P">PS Thomas</name>
</author>
<author>
<name sortKey="Sidhu, B" uniqKey="Sidhu B">B Sidhu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Carnassale, G" uniqKey="Carnassale G">G Carnassale</name>
</author>
<author>
<name sortKey="Margaritora, S" uniqKey="Margaritora S">S Margaritora</name>
</author>
<author>
<name sortKey="Vita, Ml" uniqKey="Vita M">ML Vita</name>
</author>
<author>
<name sortKey="Mariantonia, A" uniqKey="Mariantonia A">A Mariantonia</name>
</author>
<author>
<name sortKey="Congedo, Mt" uniqKey="Congedo M">MT Congedo</name>
</author>
<author>
<name sortKey="Cusumano, G" uniqKey="Cusumano G">G Cusumano</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Iqbal, M" uniqKey="Iqbal M">M Iqbal</name>
</author>
<author>
<name sortKey="Rossoff, Lj" uniqKey="Rossoff L">LJ Rossoff</name>
</author>
<author>
<name sortKey="Marzouk, Ka" uniqKey="Marzouk K">KA Marzouk</name>
</author>
<author>
<name sortKey="Steinberg, Hn" uniqKey="Steinberg H">HN Steinberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gupta, Ak" uniqKey="Gupta A">AK Gupta</name>
</author>
<author>
<name sortKey="Davies, Gm" uniqKey="Davies G">GM Davies</name>
</author>
<author>
<name sortKey="Haberman, Hf" uniqKey="Haberman H">HF Haberman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ginarte, M" uniqKey="Ginarte M">M Ginarte</name>
</author>
<author>
<name sortKey="Monteagudo, B" uniqKey="Monteagudo B">B Monteagudo</name>
</author>
<author>
<name sortKey="Toribio, J" uniqKey="Toribio J">J Toribio</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Seve, P" uniqKey="Seve P">P Sève</name>
</author>
<author>
<name sortKey="Thieblemont, C" uniqKey="Thieblemont C">C Thieblemont</name>
</author>
<author>
<name sortKey="Dumontet, C" uniqKey="Dumontet C">C Dumontet</name>
</author>
<author>
<name sortKey="Bouafia, F" uniqKey="Bouafia F">F Bouafia</name>
</author>
<author>
<name sortKey="Arnaud, P" uniqKey="Arnaud P">P Arnaud</name>
</author>
<author>
<name sortKey="Hequet, O" uniqKey="Hequet O">O Hequet</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Burrows, Np" uniqKey="Burrows N">NP Burrows</name>
</author>
<author>
<name sortKey="Jones, Rr" uniqKey="Jones R">RR Jones</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Guin, Jd" uniqKey="Guin J">JD Guin</name>
</author>
<author>
<name sortKey="Elleman, Jh" uniqKey="Elleman J">JH Elleman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mambretti Zumwalt, J" uniqKey="Mambretti Zumwalt J">J Mambretti-Zumwalt</name>
</author>
<author>
<name sortKey="Seidman, Jm" uniqKey="Seidman J">JM Seidman</name>
</author>
<author>
<name sortKey="Higano, N" uniqKey="Higano N">N Higano</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gregoire, C" uniqKey="Gregoire C">C Grégoire</name>
</author>
<author>
<name sortKey="Guiot, J" uniqKey="Guiot J">J Guiot</name>
</author>
<author>
<name sortKey="Vertenoeil, G" uniqKey="Vertenoeil G">G Vertenoeil</name>
</author>
<author>
<name sortKey="Willems, E" uniqKey="Willems E">E Willems</name>
</author>
<author>
<name sortKey="Hafraoui, K" uniqKey="Hafraoui K">K Hafraoui</name>
</author>
<author>
<name sortKey="Corhay, Jl" uniqKey="Corhay J">JL Corhay</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gupta, S" uniqKey="Gupta S">S Gupta</name>
</author>
<author>
<name sortKey="Samra, D" uniqKey="Samra D">D Samra</name>
</author>
<author>
<name sortKey="Yel, L" uniqKey="Yel L">L Yel</name>
</author>
<author>
<name sortKey="Agrawal, S" uniqKey="Agrawal S">S Agrawal</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Siegelman, Ss" uniqKey="Siegelman S">SS Siegelman</name>
</author>
<author>
<name sortKey="Heckman, Bh" uniqKey="Heckman B">BH Heckman</name>
</author>
<author>
<name sortKey="Hasson, J" uniqKey="Hasson J">J Hasson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Woollons, A" uniqKey="Woollons A">A Woollons</name>
</author>
<author>
<name sortKey="Darley, Cr" uniqKey="Darley C">CR Darley</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cockram, Cs" uniqKey="Cockram C">CS Cockram</name>
</author>
<author>
<name sortKey="Richards, P" uniqKey="Richards P">P Richards</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sakiyama, T" uniqKey="Sakiyama T">T Sakiyama</name>
</author>
<author>
<name sortKey="Shimizu, T" uniqKey="Shimizu T">T Shimizu</name>
</author>
<author>
<name sortKey="Funakoshi, T" uniqKey="Funakoshi T">T Funakoshi</name>
</author>
<author>
<name sortKey="Saito, M" uniqKey="Saito M">M Saito</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dilley, Jj" uniqKey="Dilley J">JJ Dilley</name>
</author>
<author>
<name sortKey="Kierland, Rr" uniqKey="Kierland R">RR Kierland</name>
</author>
<author>
<name sortKey="Randall, Rv" uniqKey="Randall R">RV Randall</name>
</author>
<author>
<name sortKey="Shick, Rm" uniqKey="Shick R">RM Shick</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Noel Savina, E" uniqKey="Noel Savina E">E Noël-Savina</name>
</author>
<author>
<name sortKey="Paleiron, N" uniqKey="Paleiron N">N Paleiron</name>
</author>
<author>
<name sortKey="Leroyer, C" uniqKey="Leroyer C">C Leroyer</name>
</author>
<author>
<name sortKey="Descourt, R" uniqKey="Descourt R">R Descourt</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nakielna, Em" uniqKey="Nakielna E">EM Nakielna</name>
</author>
<author>
<name sortKey="Wilson, J" uniqKey="Wilson J">J Wilson</name>
</author>
<author>
<name sortKey="Ballon, Hs" uniqKey="Ballon H">HS Ballon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Danenberg, Hd" uniqKey="Danenberg H">HD Danenberg</name>
</author>
<author>
<name sortKey="Eliashar, R" uniqKey="Eliashar R">R Eliashar</name>
</author>
<author>
<name sortKey="Flusser, G" uniqKey="Flusser G">G Flusser</name>
</author>
<author>
<name sortKey="Rosenmann, E" uniqKey="Rosenmann E">E Rosenmann</name>
</author>
<author>
<name sortKey="Chajek Shaul, T" uniqKey="Chajek Shaul T">T Chajek-Shaul</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="David Vaudey, E" uniqKey="David Vaudey E">E David-Vaudey</name>
</author>
<author>
<name sortKey="Jamard, B" uniqKey="Jamard B">B Jamard</name>
</author>
<author>
<name sortKey="Hermant, C" uniqKey="Hermant C">C Hermant</name>
</author>
<author>
<name sortKey="Cantagrel, A" uniqKey="Cantagrel A">A Cantagrel</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Runyon, Ba" uniqKey="Runyon B">BA Runyon</name>
</author>
<author>
<name sortKey="Forker, El" uniqKey="Forker E">EL Forker</name>
</author>
<author>
<name sortKey="Sopko, Ja" uniqKey="Sopko J">JA Sopko</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bokszczanin, A" uniqKey="Bokszczanin A">A Bokszczanin</name>
</author>
<author>
<name sortKey="Levinson, Ai" uniqKey="Levinson A">AI Levinson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vignes, S" uniqKey="Vignes S">S Vignes</name>
</author>
<author>
<name sortKey="Carcelain, G" uniqKey="Carcelain G">G Carcelain</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mattingly, Pc" uniqKey="Mattingly P">PC Mattingly</name>
</author>
<author>
<name sortKey="Bossingham, Dh" uniqKey="Bossingham D">DH Bossingham</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nakagomi, D" uniqKey="Nakagomi D">D Nakagomi</name>
</author>
<author>
<name sortKey="Ikeda, K" uniqKey="Ikeda K">K Ikeda</name>
</author>
<author>
<name sortKey="Kawashima, H" uniqKey="Kawashima H">H Kawashima</name>
</author>
<author>
<name sortKey="Kobayashi, Y" uniqKey="Kobayashi Y">Y Kobayashi</name>
</author>
<author>
<name sortKey="Suto, A" uniqKey="Suto A">A Suto</name>
</author>
<author>
<name sortKey="Nakajima, H" uniqKey="Nakajima H">H Nakajima</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mishra, Ak" uniqKey="Mishra A">AK Mishra</name>
</author>
<author>
<name sortKey="George, Aa" uniqKey="George A">AA George</name>
</author>
<author>
<name sortKey="George, L" uniqKey="George L">L George</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chiriac, A" uniqKey="Chiriac A">A Chiriac</name>
</author>
<author>
<name sortKey="Brzezinski, P" uniqKey="Brzezinski P">P Brzezinski</name>
</author>
<author>
<name sortKey="Foia, L" uniqKey="Foia L">L Foia</name>
</author>
<author>
<name sortKey="Marincu, I" uniqKey="Marincu I">I Marincu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Haneke, E" uniqKey="Haneke E">E Haneke</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baran, R" uniqKey="Baran R">R Baran</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tosti, A" uniqKey="Tosti A">A Tosti</name>
</author>
<author>
<name sortKey="Piraccini, Bm" uniqKey="Piraccini B">BM Piraccini</name>
</author>
<author>
<name sortKey="Cameli, N" uniqKey="Cameli N">N Cameli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baran, R" uniqKey="Baran R">R Baran</name>
</author>
<author>
<name sortKey="Rycroft, Rjg" uniqKey="Rycroft R">RJG Rycroft</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jiyad, Z" uniqKey="Jiyad Z">Z Jiyad</name>
</author>
<author>
<name sortKey="Cousins, E" uniqKey="Cousins E">E Cousins</name>
</author>
<author>
<name sortKey="Stanton, A" uniqKey="Stanton A">A Stanton</name>
</author>
<author>
<name sortKey="Mortimer, P" uniqKey="Mortimer P">P Mortimer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Abell, E" uniqKey="Abell E">E Abell</name>
</author>
<author>
<name sortKey="Samman, Pd" uniqKey="Samman P">PD Samman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ayres, S" uniqKey="Ayres S">S Ayres</name>
</author>
<author>
<name sortKey="Mihan, R" uniqKey="Mihan R">R Mihan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Williams, Hc" uniqKey="Williams H">HC Williams</name>
</author>
<author>
<name sortKey="Buffham, R" uniqKey="Buffham R">R Buffham</name>
</author>
<author>
<name sortKey="Du Vivier, A" uniqKey="Du Vivier A">A du Vivier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Arroyo, Jf" uniqKey="Arroyo J">JF Arroyo</name>
</author>
<author>
<name sortKey="Cohen, Ml" uniqKey="Cohen M">ML Cohen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tosti, A" uniqKey="Tosti A">A Tosti</name>
</author>
<author>
<name sortKey="Piraccini, Bm" uniqKey="Piraccini B">BM Piraccini</name>
</author>
<author>
<name sortKey="Iorizzo, M" uniqKey="Iorizzo M">M Iorizzo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baran, R" uniqKey="Baran R">R Baran</name>
</author>
<author>
<name sortKey="Thomas, L" uniqKey="Thomas L">L Thomas</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Doncker, Pd" uniqKey="Doncker P">PD Doncker</name>
</author>
<author>
<name sortKey="Pierard, Ge" uniqKey="Pierard G">GE Pierard</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Luyten, C" uniqKey="Luyten C">C Luyten</name>
</author>
<author>
<name sortKey="Andre, J" uniqKey="Andre J">J André</name>
</author>
<author>
<name sortKey="Walraevens, C" uniqKey="Walraevens C">C Walraevens</name>
</author>
<author>
<name sortKey="De Doncker, P" uniqKey="De Doncker P">P De Doncker</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Suzuki, M" uniqKey="Suzuki M">M Suzuki</name>
</author>
<author>
<name sortKey="Yoshizawa, A" uniqKey="Yoshizawa A">A Yoshizawa</name>
</author>
<author>
<name sortKey="Sugiyama, H" uniqKey="Sugiyama H">H Sugiyama</name>
</author>
<author>
<name sortKey="Ichimura, Y" uniqKey="Ichimura Y">Y Ichimura</name>
</author>
<author>
<name sortKey="Morita, A" uniqKey="Morita A">A Morita</name>
</author>
<author>
<name sortKey="Takasaki, J" uniqKey="Takasaki J">J Takasaki</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Imadojemu, S" uniqKey="Imadojemu S">S Imadojemu</name>
</author>
<author>
<name sortKey="Rubin, A" uniqKey="Rubin A">A Rubin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Balmforth, D" uniqKey="Balmforth D">D Balmforth</name>
</author>
<author>
<name sortKey="Bille, A" uniqKey="Bille A">A Bille</name>
</author>
<author>
<name sortKey="Okiror, L" uniqKey="Okiror L">L Okiror</name>
</author>
<author>
<name sortKey="Harrsion Phipps, K" uniqKey="Harrsion Phipps K">K Harrsion-Phipps</name>
</author>
<author>
<name sortKey="Routledge, T" uniqKey="Routledge T">T Routledge</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yamagishi, T" uniqKey="Yamagishi T">T Yamagishi</name>
</author>
<author>
<name sortKey="Hatanaka, N" uniqKey="Hatanaka N">N Hatanaka</name>
</author>
<author>
<name sortKey="Kamemura, H" uniqKey="Kamemura H">H Kamemura</name>
</author>
<author>
<name sortKey="Nakazawa, I" uniqKey="Nakazawa I">I Nakazawa</name>
</author>
<author>
<name sortKey="Hirano, Y" uniqKey="Hirano Y">Y Hirano</name>
</author>
<author>
<name sortKey="Kodaka, N" uniqKey="Kodaka N">N Kodaka</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Widjaja, A" uniqKey="Widjaja A">A Widjaja</name>
</author>
<author>
<name sortKey="Gratz, Kf" uniqKey="Gratz K">KF Gratz</name>
</author>
<author>
<name sortKey="Ockenga, J" uniqKey="Ockenga J">J Ockenga</name>
</author>
<author>
<name sortKey="Wagner, S" uniqKey="Wagner S">S Wagner</name>
</author>
<author>
<name sortKey="Manns, Mp" uniqKey="Manns M">MP Manns</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Makrilakis, K" uniqKey="Makrilakis K">K Makrilakis</name>
</author>
<author>
<name sortKey="Pavlatos, S" uniqKey="Pavlatos S">S Pavlatos</name>
</author>
<author>
<name sortKey="Giannikopoulos, G" uniqKey="Giannikopoulos G">G Giannikopoulos</name>
</author>
<author>
<name sortKey="Toubanakis, C" uniqKey="Toubanakis C">C Toubanakis</name>
</author>
<author>
<name sortKey="Katsilambros, N" uniqKey="Katsilambros N">N Katsilambros</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lotfollahi, L" uniqKey="Lotfollahi L">L Lotfollahi</name>
</author>
<author>
<name sortKey="Abedini, A" uniqKey="Abedini A">A Abedini</name>
</author>
<author>
<name sortKey="Alavi Darazam, I" uniqKey="Alavi Darazam I">I Alavi Darazam</name>
</author>
<author>
<name sortKey="Kiani, A" uniqKey="Kiani A">A Kiani</name>
</author>
<author>
<name sortKey="Fadaii, A" uniqKey="Fadaii A">A Fadaii</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hillerdal, G" uniqKey="Hillerdal G">G Hillerdal</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nakabayashi, H" uniqKey="Nakabayashi H">H Nakabayashi</name>
</author>
<author>
<name sortKey="Sagara, H" uniqKey="Sagara H">H Sagara</name>
</author>
<author>
<name sortKey="Usukura, N" uniqKey="Usukura N">N Usukura</name>
</author>
<author>
<name sortKey="Yoshimitsu, K" uniqKey="Yoshimitsu K">K Yoshimitsu</name>
</author>
<author>
<name sortKey="Imamura, T" uniqKey="Imamura T">T Imamura</name>
</author>
<author>
<name sortKey="Seta, T" uniqKey="Seta T">T Seta</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wahid, St" uniqKey="Wahid S">ST Wahid</name>
</author>
<author>
<name sortKey="Marbach, P" uniqKey="Marbach P">P Marbach</name>
</author>
<author>
<name sortKey="Stolz, B" uniqKey="Stolz B">B Stolz</name>
</author>
<author>
<name sortKey="Miller, M" uniqKey="Miller M">M Miller</name>
</author>
<author>
<name sortKey="James, Ra" uniqKey="James R">RA James</name>
</author>
<author>
<name sortKey="Ball, Sg" uniqKey="Ball S">SG Ball</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cheville, Al" uniqKey="Cheville A">AL Cheville</name>
</author>
<author>
<name sortKey="Mcgarvey, Cl" uniqKey="Mcgarvey C">CL McGarvey</name>
</author>
<author>
<name sortKey="Petrek, Ja" uniqKey="Petrek J">JA Petrek</name>
</author>
<author>
<name sortKey="Russo, Sa" uniqKey="Russo S">SA Russo</name>
</author>
<author>
<name sortKey="Taylor, Me" uniqKey="Taylor M">ME Taylor</name>
</author>
<author>
<name sortKey="Thiadens, Sr" uniqKey="Thiadens S">SR Thiadens</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lasinski, Bb" uniqKey="Lasinski B">BB Lasinski</name>
</author>
<author>
<name sortKey="Mckillip Thrift, K" uniqKey="Mckillip Thrift K">K McKillip Thrift</name>
</author>
<author>
<name sortKey="Squire, D" uniqKey="Squire D">D Squire</name>
</author>
<author>
<name sortKey="Austin, Mk" uniqKey="Austin M">MK Austin</name>
</author>
<author>
<name sortKey="Smith, Km" uniqKey="Smith K">KM Smith</name>
</author>
<author>
<name sortKey="Wanchai, A" uniqKey="Wanchai A">A Wanchai</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vignes, S" uniqKey="Vignes S">S Vignes</name>
</author>
<author>
<name sortKey="Arrault, M" uniqKey="Arrault M">M Arrault</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Decastro, A" uniqKey="Decastro A">A DeCastro</name>
</author>
<author>
<name sortKey="Mims, L" uniqKey="Mims L">L Mims</name>
</author>
<author>
<name sortKey="Hueston, Wj" uniqKey="Hueston W">WJ Hueston</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rudmik, L" uniqKey="Rudmik L">L Rudmik</name>
</author>
<author>
<name sortKey="Soler, Zm" uniqKey="Soler Z">ZM Soler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Khalil, Hs" uniqKey="Khalil H">HS Khalil</name>
</author>
<author>
<name sortKey="Nunez, Da" uniqKey="Nunez D">DA Nunez</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Orphanet J Rare Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Orphanet J Rare Dis</journal-id>
<journal-title-group>
<journal-title>Orphanet Journal of Rare Diseases</journal-title>
</journal-title-group>
<issn pub-type="epub">1750-1172</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28241848</article-id>
<article-id pub-id-type="pmc">5327582</article-id>
<article-id pub-id-type="publisher-id">594</article-id>
<article-id pub-id-type="doi">10.1186/s13023-017-0594-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Yellow nail syndrome: a review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Vignes</surname>
<given-names>Stéphane</given-names>
</name>
<address>
<phone>+33 (0) 145 30 82 35</phone>
<email>stephane.vignes@cognacq-jay.fr</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baran</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1">
<label>1</label>
Department of Lymphology, Centre National de Référence des Maladies Vasculaires Rares (Lymphœdèmes primaires), Hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France</aff>
<aff id="Aff2">
<label>2</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2188 3779</institution-id>
<institution-id institution-id-type="GRID">grid.7459.f</institution-id>
<institution></institution>
<institution>Nail Disease Centre,</institution>
</institution-wrap>
42, rue des Serbes, 06400 Cannes, France</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>27</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<elocation-id>42</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>
), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>
) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Yellow nail syndrome (YNS; OMIM 153300, ORPHA662) is a very rare disorder that almost always occurs after 50 years of age but a juvenile or familial form has also been observed. YNS is diagnosed based on a triad associating yellow nail discoloration, pulmonary manifestations (chronic cough, bronchiectasia, pleural effusion) and lower limb lymphedema. Chronic sinusitis is frequently associated with the triad. YNS etiology remains unknown but a role of lymphatic impairment is usually evoked. YNS is more frequently isolated but may be associated in rare cases with autoimmune diseases, other clinical manifestations implicating lymphatic functions or cancer and, hence, is also considered a paraneoplastic syndrome. YNS management is symptomatic and not codified. YNS can resolve spontaneously. Oral vitamin E alone or even better when associated with triazole antifungals may achieve partial or total disappearance of nail discoloration. Pleural effusion can be treated surgically, with decortication/pleurectomy or pleurodesis. Antibiotic prophylaxis is prescribed for bronchiectasia with chronic sputum production. Lymphedema treatment is based on low-stretch bandages and the wearing of elastic compression garments combined with skin care, exercises and, as needed, manual lymph drainage.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Yellow nail syndrome</kwd>
<kwd>Respiratory manifestations</kwd>
<kwd>Sinusitis</kwd>
<kwd>Lymphedema</kwd>
<kwd>Review</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>The first case of yellow nail syndrome (YNS; OMIM 153300, ORPHA662) was probably reported by Heller in 1927 [
<xref ref-type="bibr" rid="CR1">1</xref>
], but Samman & White described the first series of patients who had yellow nails associated with lymphedema in 1964 [
<xref ref-type="bibr" rid="CR2">2</xref>
]. That report included 13 patients (six men, seven women; age range at onset 25–65 years), all of whom had very slow measured nail growth associated with abnormal nail-plate discoloration, ranging from pale yellow to dark greenish, and frequent onycholysis. Eight of them had ankle edema; one patient each had facial edema or Milroy’s disease (familial form of primary lymphedema). Four patients’ limb lymphangiograms showed lymphatic abnormalities, such as tortuous, dilated or hypoplastic vessels, which the authors considered suggestive of lymphatic dysfunction or defective lymph drainage being responsible for YNS. In this review, we analyze the available literature on this subject, describing clinical characteristics, explorations, associated diseases and management of this rare syndrome.</p>
</sec>
<sec id="Sec2">
<title>Methodology</title>
<p>The literature search of the PubMed database used the words “yellow nail syndrome” for articles written in English or French. Other references cited in the identified articles were also considered.</p>
</sec>
<sec id="Sec3">
<title>Definition</title>
<p>YNS is characterized by a triad of thickened yellow nails, primary lymphedema and respiratory manifestations. It is an acquired condition of unknown etiology. It is a syndrome – not a disease – that is associated with conditions as different as diseases implicating the lymphatic system, autoimmune diseases or cancers. Whereas Samman & White’s first description of YNS included only nail discoloration, Emerson added pleural effusion to the diagnostic criteria [
<xref ref-type="bibr" rid="CR3">3</xref>
]. Among the three clinical YNS characteristics (yellow nail syndrome, respiratory tract involvement, lymphedema), only two are required to diagnose YNS but it is difficult to call the entity YNS without nail abnormality [
<xref ref-type="bibr" rid="CR4">4</xref>
]. Moreover, the three components are not necessarily present simultaneously, and may appear individually and sequentially, thereby making YNS diagnosis difficult. The complete triad is present only in 27–60% of the patients [
<xref ref-type="bibr" rid="CR5">5</xref>
<xref ref-type="bibr" rid="CR10">10</xref>
] (Table 
<xref rid="Tab1" ref-type="table">1</xref>
). The percentage differences of a given clinical manifestation may be attributed to the medical specialty that recruited the patients.
<table-wrap id="Tab1">
<label>Table 1</label>
<caption>
<p>YNS clinical manifestations found in six large series of patients</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Manifestation</th>
<th>Maldonado et al. [
<xref ref-type="bibr" rid="CR6">6</xref>
],
<italic>N</italic>
 = 41</th>
<th>Hoque et al. [
<xref ref-type="bibr" rid="CR5">5</xref>
],
<italic>N</italic>
 = 11</th>
<th>Piraccini et al. [
<xref ref-type="bibr" rid="CR7">7</xref>
],
<italic>N</italic>
 = 21</th>
<th>Nordkild et al. [
<xref ref-type="bibr" rid="CR8">8</xref>
],
<italic>N</italic>
 = 97</th>
<th>Varney et al. [
<xref ref-type="bibr" rid="CR9">9</xref>
],
<italic>N</italic>
 = 17</th>
<th>Pavlidakey et al. [
<xref ref-type="bibr" rid="CR10">10</xref>
],
<italic>N</italic>
 = 62</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yellow nails,
<italic>n</italic>
(%)</td>
<td>41 (100)</td>
<td>10 (91)</td>
<td>21 (100)</td>
<td>86 (89)</td>
<td>17 (100)</td>
<td>53 (85)</td>
</tr>
<tr>
<td>Chronic pulmonary manifestations,
<italic>n</italic>
(%)</td>
<td>23 (56)</td>
<td>7 (64)</td>
<td>15 (71)</td>
<td>61 (63)</td>
<td>17 (100)</td>
<td>24 (39) (PEs only)</td>
</tr>
<tr>
<td>Lymphedema,
<italic>n</italic>
(%)</td>
<td>26 (63)</td>
<td>6 (55)</td>
<td>6 (29)</td>
<td>78 (80)</td>
<td>13 (76)</td>
<td>45 (72)</td>
</tr>
<tr>
<td>Sinusitis,
<italic>n</italic>
(%)</td>
<td>17 (41)</td>
<td>3 (27)</td>
<td>3 (14)</td>
<td>NR</td>
<td>14 (83)</td>
<td>11 (18)</td>
</tr>
<tr>
<td>Complete triad</td>
<td>~60%</td>
<td>27%</td>
<td>29%</td>
<td>NR</td>
<td>76%</td>
<td>27%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>
<italic>PEs</italic>
pleural effusions,
<italic>NR</italic>
not reported</p>
</table-wrap-foot>
</table-wrap>
</p>
</sec>
<sec id="Sec4">
<title>Epidemiology</title>
<p>No precise data are available to determine the exact prevalence of YNS, as fewer than 400 cases have been published in the literature, with an estimated prevalence <1/1,000,000. Cases have been described in all countries worldwide. YNS most often occurs in adults over 50 years old, with no sex predominance [
<xref ref-type="bibr" rid="CR5">5</xref>
<xref ref-type="bibr" rid="CR7">7</xref>
]. Pediatric forms are very rarely reported [
<xref ref-type="bibr" rid="CR11">11</xref>
<xref ref-type="bibr" rid="CR21">21</xref>
]: YNS may be present at birth (congenital) or develop before the age of 10 years [
<xref ref-type="bibr" rid="CR8">8</xref>
].</p>
<p>A familial form of YNS has very rarely been described [
<xref ref-type="bibr" rid="CR5">5</xref>
,
<xref ref-type="bibr" rid="CR22">22</xref>
<xref ref-type="bibr" rid="CR24">24</xref>
], affecting two siblings [
<xref ref-type="bibr" rid="CR25">25</xref>
,
<xref ref-type="bibr" rid="CR26">26</xref>
] or a family with eight cases in four sibships over two generations [
<xref ref-type="bibr" rid="CR22">22</xref>
]. The very few reported familial cases mimic a dominant inheritance pattern, which is not supported by any genetic evidence [
<xref ref-type="bibr" rid="CR5">5</xref>
]. YNS may be associated with intellectual disability, in which case it evokes a more complex syndrome [
<xref ref-type="bibr" rid="CR25">25</xref>
] or occurs in cases of consanguinity [
<xref ref-type="bibr" rid="CR17">17</xref>
].</p>
</sec>
<sec id="Sec5" sec-type="materials|methods">
<title>Diagnosis and diagnostic methods</title>
<sec id="Sec6">
<title>Yellow nails</title>
<p>Yellow nails are the main clinical manifestation leading to YNS diagnosis. However, the possible interval between the first clinical sign (lymphedema, lung manifestations) and nail discoloration hinders affirmation of the YNS diagnosis. That yellowing represents a subset of chromonychia, defined as pathological nail discoloration, especially xanthonychia (yellow nail coloration). Nail discoloration varies from pale yellow to more or less dark greenish [
<xref ref-type="bibr" rid="CR27">27</xref>
]. The nail plate becomes thickened, with an enhanced transverse curvature (overcurvature), sometimes with a notable hump, cross-ridging, very hard (scleronychia) and difficult-to-trim nail, and cuticle disappearance [
<xref ref-type="bibr" rid="CR28">28</xref>
]. Usually opaque, the lunula disappears because of nail hyperkeratosis [
<xref ref-type="bibr" rid="CR27">27</xref>
] (Fig. 
<xref rid="Fig1" ref-type="fig">1</xref>
). Erythema may be seen in the proximal nail fold, frequently associated with chronic paronychia). Onycholysis (distal nail plate–nail bed separation) may occur with possible proximal spreading, leading to complete nail shedding [
<xref ref-type="bibr" rid="CR29">29</xref>
,
<xref ref-type="bibr" rid="CR30">30</xref>
]. Longitudinal growth of the affected nail (0.23 mm per week) was half that of a normal nail (0.46 mm per week) [
<xref ref-type="bibr" rid="CR2">2</xref>
,
<xref ref-type="bibr" rid="CR31">31</xref>
]. The affected nail’s thickness (0.97 mm) was double that of a normal nail (0.57 mm), suggesting that the nail that grows half as fast and twice as thick [
<xref ref-type="bibr" rid="CR31">31</xref>
].
<fig id="Fig1">
<label>Fig. 1</label>
<caption>
<p>Yellowing of all 10 (
<bold>a</bold>
) finger and (
<bold>b</bold>
) toe nails</p>
</caption>
<graphic xlink:href="13023_2017_594_Fig1_HTML" id="MO1"></graphic>
</fig>
</p>
</sec>
<sec id="Sec7">
<title>Pulmonary manifestations</title>
<p>Lung involvement in YNS, which occurred in 56–71% of the patients, diversely affected some parts of the respiratory tract with a variety of clinical manifestations [
<xref ref-type="bibr" rid="CR6">6</xref>
<xref ref-type="bibr" rid="CR8">8</xref>
]. Chronic cough is the most frequent pulmonary manifestation seen in 56% of YNS patients [
<xref ref-type="bibr" rid="CR6">6</xref>
], with pleural effusions found in 14–46% of the patients [
<xref ref-type="bibr" rid="CR6">6</xref>
,
<xref ref-type="bibr" rid="CR7">7</xref>
].</p>
<p>Based on their retrospective systematic review of more than 150 patients described in publications identified with the search terms “pleural effusion” and “YNS”, Valdés et al. recently reported the characteristics of these pleural effusions [
<xref ref-type="bibr" rid="CR32">32</xref>
]: 68.3% were bilateral; the fluid appeared serous in 75%, milky (chylothorax) in 22% and purulent (empyemas) in 3.5%; 95% of effusions were described as exudates (median protein level: 4.2 g/dl) and 5% as transudates that harbored a median nucleated cell count of 1540 cells/mm
<sup>3</sup>
with 96% lymphocytic predominance.</p>
<p>However, sputum bacteria (
<italic>Pseudomonas aeruginosa</italic>
,
<italic>Haemophilus influenzae</italic>
,
<italic>Streptococcus pneumoniae</italic>
,
<italic>Moraxella catarrhalis</italic>
) are the same in idiopathic and YNS-associated bronchiectasias [
<xref ref-type="bibr" rid="CR33">33</xref>
]. Recurrent pneumonias occur in 22% of the patients. Also, bilateral apical fibrosis, patchy alveolar infiltrates and cystic lesions are very rarely observed in YNS patients [
<xref ref-type="bibr" rid="CR33">33</xref>
,
<xref ref-type="bibr" rid="CR34">34</xref>
].</p>
<p>YNS patients’ pulmonary function test results are usually normal or may indicate a moderate-to-severe restrictive syndrome attributable to pleural effusions [
<xref ref-type="bibr" rid="CR4">4</xref>
]. Extremely rare patients may have mixed obstructive–restrictive syndrome or decreased diffusion capacity [
<xref ref-type="bibr" rid="CR6">6</xref>
]. Histological examination of pleural biopsies revealed normal morphology or that of chronic fibrosing pleuritis, and did not provide any further information; biopsies are usually not contributive [
<xref ref-type="bibr" rid="CR32">32</xref>
]. Bronchiectasias are present in 44%. Chest computed-tomography (CT) scan is the best imaging technique to diagnose bronchiectasia, which, in YNS patients, is significantly less extensive, severe and with lower bronchial wall thickness scores than in matched idiopathic bronchiectasia patients [
<xref ref-type="bibr" rid="CR33">33</xref>
].</p>
</sec>
<sec id="Sec8">
<title>Lymphedema</title>
<p>Lymphedema is a clinical feature of YNS, occurring in 29–80% of the reported series, and may be the first sign of the disease in about one-third of them [
<xref ref-type="bibr" rid="CR6">6</xref>
<xref ref-type="bibr" rid="CR8">8</xref>
]. Lymphedema characteristics do not differ from those of primary lymphedema. It involves the lower limbs, especially bilateral and below the knee (Fig. 
<xref rid="Fig2" ref-type="fig">2</xref>
). The increased volume of the lymphedematous limb is caused by excess lymph accumulation but also fibrosis resulting from fibroblast stimulation and excess adipose tissue due to adipocyte stimulation [
<xref ref-type="bibr" rid="CR35">35</xref>
,
<xref ref-type="bibr" rid="CR36">36</xref>
]. Stemmer’s sign (inability to pinch the skin on the dorsal side or the base of the second toe) is pathognomonic of lymphedema and is fibrosis-related. Superficial edema is responsible for the more-or-less present pitting edema. Lymphedema is a chronic disease, with a major tissular component leading to incomplete reversibility under treatment. Although cellulitis (erysipelas) is the main lymphedema complication, discomfort, esthetic prejudice and diminished quality of life also complicate the disease [
<xref ref-type="bibr" rid="CR37">37</xref>
,
<xref ref-type="bibr" rid="CR38">38</xref>
].
<fig id="Fig2">
<label>Fig. 2</label>
<caption>
<p>Bilateral lower limb lymphedema involving the feet, ankles and calves, with accentuation of the flexion folds</p>
</caption>
<graphic xlink:href="13023_2017_594_Fig2_HTML" id="MO2"></graphic>
</fig>
</p>
</sec>
<sec id="Sec9">
<title>Sinusitis</title>
<p>Acute or chronic rhinosinusitis is very common in YNS patients, estimated between 14 and 83% [
<xref ref-type="bibr" rid="CR5">5</xref>
<xref ref-type="bibr" rid="CR10">10</xref>
]. The maxillary sinus is the most frequently affected, followed by ethmoid, frontal and sphenoid [
<xref ref-type="bibr" rid="CR9">9</xref>
] (Fig. 
<xref rid="Fig3" ref-type="fig">3</xref>
). Nasal symptom onset may precede nail changes by a few years, appear simultaneously or arise subsequently. Clinical signs include daily mucopurulent rhinorrhea, nasal obstruction and frequent post-nasal drip. Nasal airway examination usually finds narrowed nasal pathways, mucosal inflammation with variable enlargement of the turbinates and the presence of mucopus. Other symptoms may be associated, e.g., headaches or recurrent facial pain. Non-contrast sinus CT scans show mucosal thickening, with fluid levels sometimes reported.
<fig id="Fig3">
<label>Fig. 3</label>
<caption>
<p>Sinus computed-tomography scan: note the subtotal opacity of the left maxillary sinus and ethmoidal sinusitis</p>
</caption>
<graphic xlink:href="13023_2017_594_Fig3_HTML" id="MO3"></graphic>
</fig>
</p>
</sec>
<sec id="Sec10">
<title>Other manifestations</title>
<p>Very rare ocular involvement has been reported: chemosis, corneal micropannus (vascularized sheet of fibrous tissue overlying the cornea), eyelid lymphedema, thickened conjunctiva [
<xref ref-type="bibr" rid="CR39">39</xref>
,
<xref ref-type="bibr" rid="CR40">40</xref>
]. Anecdotal associations have also been described: anhydrosis, pectus excavatum, eosinophilia–myalgia syndrome, bullous stomatitis, sarcoidosis and Raynaud’s phenomenon, cerebral aneurysm and pancytopenia [
<xref ref-type="bibr" rid="CR6">6</xref>
].</p>
</sec>
<sec id="Sec11">
<title>Children</title>
<p>Among children with YNS, 75% had lung manifestations (infections, pleural effusions, bronchial dilations and/or bronchial cysts) and ear-nose-throat symptoms in 31%, with a moderate female predominance [
<xref ref-type="bibr" rid="CR20">20</xref>
]. Lymphedema prevalence ranged from 56 to 80% of YNS children and may appear later than the nail discoloration [
<xref ref-type="bibr" rid="CR8">8</xref>
].</p>
</sec>
</sec>
<sec id="Sec12">
<title>Pathogenesis</title>
<p>Although YNS etiology of remains unknown, some hypotheses were advanced. Lymphatic involvement is often evoked to explain lymphedema, pleural effusion (particularly chylothorax) or nail discoloration but it is difficult to implicate it in bronchiectasia and sinusitis. Lymphatic impairment is not easy to confirm. Four YNS patients underwent lower limb direct lymphangiography, less used at present, but lymphatic abnormalities were noted only in the patient with severe lymphedema. Quantitative limb lymphoscintigraphy with
<sup>99m</sup>
Tc-colloidal antimony sulfide revealed less activity (percentage uptake) in the draining lymph nodes (inguinofemoral or axillary) [
<xref ref-type="bibr" rid="CR41">41</xref>
]. Moreover, the uptake percentages in the axillary/inguinal lymph nodes of the YNS group were significantly lower than those of the normal controls but significantly higher than those of subjects with primary or secondary lymphedema, hence more suggestive of impaired lymph transport than the lymphatic hypoplasia/aplasia seen in true primary lymphedema. Furthermore, the YNS group without lower limb edema had better lymphatic drainage than those with edema [
<xref ref-type="bibr" rid="CR42">42</xref>
] (Fig. 
<xref rid="Fig4" ref-type="fig">4</xref>
). Maldonado et al. thought that YNS pathophysiology might be attributable to microvasculopathy associated with protein leakage rather than functional lymphatic impairment [
<xref ref-type="bibr" rid="CR43">43</xref>
]. Notably, nailfold capillaroscopy occasionally showed dilated and tortuous capillary loops [
<xref ref-type="bibr" rid="CR44">44</xref>
].
<fig id="Fig4">
<label>Fig. 4</label>
<caption>
<p>Lower-limb lymphoscintigraphy images were obtained 40 min after injecting
<sup>99m</sup>
technetium-labeled colloidal albumin into two patients with the complete YNS triad: moderate lymphostasis and slightly decreased (
<bold>a</bold>
) or absent (
<bold>b</bold>
) inguinal lymph-node uptake</p>
</caption>
<graphic xlink:href="13023_2017_594_Fig4_HTML" id="MO4"></graphic>
</fig>
</p>
<p>Defective lymphatic drainage might be responsible for the slow growth and thickened nails observed in YNS, and may reflect subungual tissue sclerosis leading to lymphatic obstruction. Light microscopy examination of sections of nail-matrix tissue revealed replacement of the normally loose fibrovascular subungual stroma by dense, fibrous tissue (composed of dense collagen deposits) extending from the immediate subepithelial stroma to a depth of 2.5 mm. Numerous ectatic, endothelium-lined channels were prominent within the fibrotic stroma [
<xref ref-type="bibr" rid="CR45">45</xref>
]. Fibrosis and dilated lymphatic vessels were also seen in the parietal pleura of a YNS patient [
<xref ref-type="bibr" rid="CR46">46</xref>
,
<xref ref-type="bibr" rid="CR47">47</xref>
]. The accumulation of lipofuscin pigment was advanced to explain the yellow discoloration [
<xref ref-type="bibr" rid="CR48">48</xref>
], whereas abnormal nail keratinization might be explained by the presence electron microscopy-visualized keratohyalin granules, not found in normal adult nails.</p>
<p>More recently, it was hypothesized that titanium, especially titanium dioxide, might play a role in YNS. High titanium levels (determined by energy dispersive X-ray fluorescence) were detected in the nails of YNS patients but not in control nails. The authors postulated that titanium ions were released from titanium implants (inlays, crown) in the teeth or jaws through the galvanic action of amalgam or localized oxidative action of fluorides [
<xref ref-type="bibr" rid="CR49">49</xref>
<xref ref-type="bibr" rid="CR51">51</xref>
]. Other sources of titanium ions were also suggested: joint implants, surgical staples, foods (chewing gum to try to explain YNS in children), medication excipients, cosmetics (sunscreen, moisturizers, shampoo, toothpaste) [
<xref ref-type="bibr" rid="CR50">50</xref>
,
<xref ref-type="bibr" rid="CR52">52</xref>
]. Titanium’s hypothetical role remains possible, but probably not sufficient, because its presence in other organs (liver, spleen, lymph nodes, lung) of autopsied patients was not accompanied with nail yellowing [
<xref ref-type="bibr" rid="CR53">53</xref>
].</p>
</sec>
<sec id="Sec13">
<title>Associated diseases</title>
<p>Several infants had YNS associated with non-immune hydrops fetalis; this association is probably not fortuitous [
<xref ref-type="bibr" rid="CR54">54</xref>
]. Non-immune hydrops fetalis was present at birth [
<xref ref-type="bibr" rid="CR20">20</xref>
,
<xref ref-type="bibr" rid="CR55">55</xref>
]. A child with YNS had a brother who died of non-immune hydrops fetalis, suggesting a possible relationship between the two diseases [
<xref ref-type="bibr" rid="CR17">17</xref>
].</p>
<p>YNS is very rarely associated with primary intestinal lymphangiectasia (Waldmann’s disease) (OMIM 152800, ORPHA90362) or lymphedema–distichiasis syndrome (OMIM 153400, ORPHA33001), suggesting that these entities have overlapping characteristics, including lymphatic impairment [
<xref ref-type="bibr" rid="CR56">56</xref>
,
<xref ref-type="bibr" rid="CR57">57</xref>
]. Waldmann’s disease is characterized by primary intestinal lymphangiectasia, with lymph leakage into the bowel lumen leading to hypoalbuminemia, hypogammaglobulinemia and lymphopenia [
<xref ref-type="bibr" rid="CR58">58</xref>
]. Distichiasis is defined as double or more rows of eyelashes localized on the Meibomian gland orifices [
<xref ref-type="bibr" rid="CR59">59</xref>
].</p>
<p>The YNS association with malignant disease raises the hypothesis that it might be a paraneoplastic syndrome but that notion remains controversial. The frequency of cancer being diagnosed concurrently or closely thereafter in YNS patients was estimated at 4/41 [
<xref ref-type="bibr" rid="CR6">6</xref>
] and 1/21 [
<xref ref-type="bibr" rid="CR7">7</xref>
]. Various types of cancers were associated with YNS: bronchial carcinoma [
<xref ref-type="bibr" rid="CR60">60</xref>
,
<xref ref-type="bibr" rid="CR61">61</xref>
], breast [
<xref ref-type="bibr" rid="CR7">7</xref>
,
<xref ref-type="bibr" rid="CR62">62</xref>
,
<xref ref-type="bibr" rid="CR63">63</xref>
], non-Hodgkin lymphoma [
<xref ref-type="bibr" rid="CR64">64</xref>
,
<xref ref-type="bibr" rid="CR65">65</xref>
], gallbladder [
<xref ref-type="bibr" rid="CR6">6</xref>
,
<xref ref-type="bibr" rid="CR66">66</xref>
], larynx [
<xref ref-type="bibr" rid="CR67">67</xref>
], renal cell carcinoma [
<xref ref-type="bibr" rid="CR6">6</xref>
], endometrium [
<xref ref-type="bibr" rid="CR68">68</xref>
], melanoma [
<xref ref-type="bibr" rid="CR3">3</xref>
], multiple myeloma after hematopoietic stem-cell transplantation [
<xref ref-type="bibr" rid="CR69">69</xref>
] or precancerous mycosis fungoides [
<xref ref-type="bibr" rid="CR28">28</xref>
]. The YNS-to-cancer-diagnosis interval ranges from days to years, with gradual development of the complete YNS triad [
<xref ref-type="bibr" rid="CR61">61</xref>
].</p>
<p>YNS was occasionally associated with autoimmune diseases [
<xref ref-type="bibr" rid="CR70">70</xref>
], immunodeficiency disorders, such as common variable immunodeficiency, combined T- and B-cell deficiency [
<xref ref-type="bibr" rid="CR70">70</xref>
,
<xref ref-type="bibr" rid="CR71">71</xref>
], Guillain–Barré syndrome [
<xref ref-type="bibr" rid="CR72">72</xref>
], nephrotic syndrome [
<xref ref-type="bibr" rid="CR73">73</xref>
,
<xref ref-type="bibr" rid="CR74">74</xref>
], Hashimoto’s thyroiditis, severe hypothyroidism or hyperthyroidism [
<xref ref-type="bibr" rid="CR75">75</xref>
<xref ref-type="bibr" rid="CR77">77</xref>
], xanthogranulomatous pyelonephritis [
<xref ref-type="bibr" rid="CR78">78</xref>
] and rheumatoid arthritis even without thiol-analog use [
<xref ref-type="bibr" rid="CR79">79</xref>
].</p>
<p>Immunological studies on YNS patients are very scarce. Isolated case reports associated YNS with IgA deficiency [
<xref ref-type="bibr" rid="CR22">22</xref>
] or hypogammaglobulinemia [
<xref ref-type="bibr" rid="CR80">80</xref>
]. Bokszczanin & Levinson described a 57-year-old woman with YNS and poor selective responses after vaccination against
<italic>Streptococcus pneumoniae</italic>
and
<italic>Haemophilus influenzae</italic>
[
<xref ref-type="bibr" rid="CR81">81</xref>
], which might explain, in part, the recurrent lung or sinus infections in YNS. Gupta et al. reported lymphopenia in two YNS patients (one with common variable immunodeficiency) with low percentages of CD4
<sup>+</sup>
T cells, high percentages of CD8
<sup>+</sup>
T cells and severe naïve CD4
<sup>+</sup>
and CD8
<sup>+</sup>
T-cell deficits responsible for muted T-cell responses to antigens. A suggested mechanism for diminished naïve T-cell subsets might be less thymus output (thymus involution and/or apoptosis) [
<xref ref-type="bibr" rid="CR70">70</xref>
]. It is of interest to note that, in another rare disease with lymphatic abnormality, primary intestinal lymphangiectasia (Waldmann’s disease), immunological investigation results were similar to those of YNS patients [
<xref ref-type="bibr" rid="CR82">82</xref>
].</p>
</sec>
<sec id="Sec14">
<title>Differential diagnosis of nail discoloration</title>
<sec id="Sec15">
<title>Drugs</title>
<p>
<sc>d</sc>
-Penicillamine, bucillamine and tiopronin are three thiol compounds used for long-term treatment of rheumatoid arthritis. For the rare cases of drug-related YNS, nail discoloration was the first manifestation in 88% of them, but it was less frequently associated with pleural effusion and lymphedema than in YNS not drug-related [
<xref ref-type="bibr" rid="CR83">83</xref>
,
<xref ref-type="bibr" rid="CR84">84</xref>
]. Competitive inhibition of disulfide-binding in keratin biosynthesis is postulated to explain the major slowing of nail plate growth in bucillamine-treated patients. Moreover, thiol drugs contain cysteine, which is also a major nail component. After bucillamine withdrawal, nail discoloration declined in over 90% of the affected patients but lymphedema and pulmonary manifestations were attenuated in only 30–35% [
<xref ref-type="bibr" rid="CR84">84</xref>
]. Gold and methotrexate, also used to treat rheumatoid arthritis, are less suspected of being associated with YNS [
<xref ref-type="bibr" rid="CR85">85</xref>
].</p>
</sec>
<sec id="Sec16">
<title>Infections</title>
<p>Nail yellowing is abnormal and may be attributable to something other than YNS. Nail infection or mycosis should be ruled out before considering YNS.
<italic>Candida-, Aspergillus-</italic>
or dermatophyte-caused nail mycosis may cause such discoloration.
<italic>Pseudomonas aeruginosa</italic>
, via production of the blue–green pigments pyoverdin and pyocyanin, may be responsible for chloronychia (green rather than yellow nail discoloration) in the elderly [
<xref ref-type="bibr" rid="CR86">86</xref>
]. Chloronychia is more common in homemakers, barbers, dishwashers, bakers and medical personnel.</p>
</sec>
<sec id="Sec17">
<title>Others</title>
<p>In children and adults, differential diagnoses include planus lichen, psoriasis or alopecia areata, chronic paronychia, onychogryphosis and acquired pachyonychia [
<xref ref-type="bibr" rid="CR87">87</xref>
<xref ref-type="bibr" rid="CR89">89</xref>
]. Yellow nail discoloration may also have rare local and toxic causes (Table 
<xref rid="Tab2" ref-type="table">2</xref>
) [
<xref ref-type="bibr" rid="CR90">90</xref>
].
<table-wrap id="Tab2">
<label>Table 2</label>
<caption>
<p>Rare, usually work-related, local toxic causes of yellow nail discoloration, from [
<xref ref-type="bibr" rid="CR90">90</xref>
]</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td>Epoxy systems: metaphenylenediamine, 4,4′-methylenedianiline</td>
</tr>
<tr>
<td>Flower handling</td>
</tr>
<tr>
<td>Pesticides: diquat, paraquat, dinitroorthocresol, dinobuton</td>
</tr>
<tr>
<td>Chromium salts</td>
</tr>
<tr>
<td>Dyestuffs: dinitrosalicylic acid, dinitrobenzene, dinitrotoluene, trinitrotoluene</td>
</tr>
</tbody>
</table>
</table-wrap>
</p>
</sec>
</sec>
<sec id="Sec18">
<title>Treatment</title>
<p>YNS treatment is not codified. YNS may resolve in few months without treatment [
<xref ref-type="bibr" rid="CR91">91</xref>
] or, when it is a paraneoplastic syndrome, after cancer therapy [
<xref ref-type="bibr" rid="CR62">62</xref>
].</p>
<sec id="Sec19">
<title>Yellow nail changes</title>
<p>The main aim is to improve the frequently unesthetic nail appearance and associated pain, due, in part, to onycholysis. A few drugs have been proposed to treat the nail discoloration with inconsistent efficacy. None of the following treatments can be recommended systematically to treat YNS.</p>
<sec id="Sec20">
<title>Systemic treatments of yellow nails</title>
<p>Oral vitamin E is the only agent that successfully treated YNS [
<xref ref-type="bibr" rid="CR48">48</xref>
,
<xref ref-type="bibr" rid="CR92">92</xref>
<xref ref-type="bibr" rid="CR95">95</xref>
]. Oral α-tocopherol (vitamin E) was frequently prescribed at 1000–1200 IU/day, with incomplete or inconstant efficacy. Norton’s hypothesized, as follows, that vitamin E would be effective: lipofuscin pigments, possibly responsible for nail yellowing, are derived from colorless lipid precursors, transformed by oxidation in tissue to produce varying degrees of yellow; vitamin E has proven in vitro antioxidant properties, and in vivo might protect cell membranes against free-radical–mediated oxidative damage, thereby potentially blocking lipofuscin-pigment production [
<xref ref-type="bibr" rid="CR48">48</xref>
].</p>
<p>Although YNS is not caused by fungal infection, triazole antifungals were regularly used to treat it. Itraconazole, given at 400 mg/day for 1 week/month for 6 months, achieved only two mild attenuations and two cures among eight patients (one relapsed after drug discontinuation) [
<xref ref-type="bibr" rid="CR96">96</xref>
]. Among the 13 patients who took oral fluconazole (300 mg once weekly) and oral α-tocopherol (1000 IU/day), two benefited from clinical improvement and 11 were considered clinical cures [
<xref ref-type="bibr" rid="CR97">97</xref>
], without any efficacy on other YNS manifestations. One of the hypotheses to explain that partial efficacy is based on azole antifungal stimulation of linear nail growth [
<xref ref-type="bibr" rid="CR98">98</xref>
,
<xref ref-type="bibr" rid="CR99">99</xref>
].</p>
<p>Oral zinc sulfate supplementation (300 mg daily) obtained attenuation of nail yellowing or growth and lymphedema after 8 months of treatment but no modification of pulmonary manifestations [
<xref ref-type="bibr" rid="CR95">95</xref>
].</p>
<p>Clarithromycin (400 mg/day, 6 years) successfully treated one patient [
<xref ref-type="bibr" rid="CR100">100</xref>
].</p>
<p>A patient with common variable immunodeficiency treated with subcutaneous immunoglobulin mounted good responses in terms of frequency of infections, lymphedema and pleural effusions [
<xref ref-type="bibr" rid="CR70">70</xref>
].</p>
</sec>
<sec id="Sec21">
<title>Local treatments</title>
<p>Intralesional steroids, such as topical triamcinolone acetonide (5 mg/ml/injection, 0.1–0.2 ml for each affected nail), were proposed alone or combined with fluconazole and vitamin E [
<xref ref-type="bibr" rid="CR92">92</xref>
,
<xref ref-type="bibr" rid="CR101">101</xref>
].</p>
<p>In a first study published in 1991, Williams et al. prescribed topical vitamin E; the treated nails improved clinically and growth rates rose [
<xref ref-type="bibr" rid="CR94">94</xref>
]. In a randomized study using a vitamin E preparation (solution of 20,000 IU of tocopherol acetate/fluid ounce of safflower oil) applied twice daily to the nails), no difference (appearance or nail growth) versus placebo was observed after 6 months of administration [
<xref ref-type="bibr" rid="CR23">23</xref>
].</p>
</sec>
</sec>
<sec id="Sec22">
<title>Pulmonary manifestations</title>
<p>Symptomatic treatments are prescribed. Patients may receive antibiotics for acute exacerbation of bronchiectasia, whereas, for patients with poor symptom control and/or recurrent exacerbations, low-dose antibiotic prophylaxis, such as oral azithromycin (usually 250 mg 3 times/week), achieved attenuation of chest symptoms for the majority of them [
<xref ref-type="bibr" rid="CR33">33</xref>
]. Physiotherapy training (postural drainage, chest physiotherapy, flutter valve), combined or not with antibiotic prophylaxis, is also prescribed to help patients self-manage their chronic expectoration.</p>
<p>Vaccinations against flu and pneumococci are strongly recommended. Surgical intervention of recurrent and/or large pleural effusions is useful: decortication/pleurectomy, pleurodesis (talc [
<xref ref-type="bibr" rid="CR47">47</xref>
,
<xref ref-type="bibr" rid="CR102">102</xref>
], picibanil [
<xref ref-type="bibr" rid="CR103">103</xref>
], quinacrine [
<xref ref-type="bibr" rid="CR4">4</xref>
]) and pleural–peritoneal shunts were the most effective treatments of symptomatic pleural effusions with, respectively, 89, 82 and 67% partial or complete responses [
<xref ref-type="bibr" rid="CR33">33</xref>
].</p>
<p>Octreotide, a somatostatin analog, was also used to treat YNS pleural effusions or chylous ascites and lymphedema, and generated positive responses [
<xref ref-type="bibr" rid="CR47">47</xref>
,
<xref ref-type="bibr" rid="CR104">104</xref>
<xref ref-type="bibr" rid="CR107">107</xref>
]. Somatostatin analogues reduce intestinal lipid absorption and lower the triglyceride concentration in the thoracic duct in animals [
<xref ref-type="bibr" rid="CR108">108</xref>
]. Those actions could explain the diminution of the chylous but not non-chylous effusions present in most YNS patients. Octreotide was initially administered subcutaneously (0.5 mg twice daily) to ensure safety, followed by the long-acting repeatable formulation (30 mg given once/month) with or without progressive dose diminution [
<xref ref-type="bibr" rid="CR105">105</xref>
,
<xref ref-type="bibr" rid="CR107">107</xref>
]. One initial octreotide responder became “resistant”, suggesting tachyphylaxis to long-lasting treatment, as previously described for acromegaly patients receiving chronic treatment. Lanreotide, an alternative somatostatin analog, may be useful for such cases [
<xref ref-type="bibr" rid="CR47">47</xref>
,
<xref ref-type="bibr" rid="CR109">109</xref>
].</p>
</sec>
<sec id="Sec23">
<title>Lymphedema</title>
<p>Complete decongestive therapy, also called complex or multimodal decongestive physiotherapy, is the term proposed by Michael Földi in the 1980s to define lymphedema treatment. This approach is divided into two separate phases [
<xref ref-type="bibr" rid="CR110">110</xref>
]. The first, intended to obtain the most important lymphedema-volume reduction, is comprised of several components: low-stretch bandage, manual lymph drainage, skin/nail care (to detect and eliminate potential sites of entry for infection) and exercises, each having its own specific objective and role in limiting the impact of this disorder. The intensive strategy of this stage aims to achieve 30–40% lymphedema-volume reduction [
<xref ref-type="bibr" rid="CR111">111</xref>
], eliminating only the fluid component of lymphedema. The second phase of complete decongestive therapy helps stabilize lymphedema volume over the long-term and is based on wearing a high-pressure elastic garment, exercises, skin care and, sometimes, manual lymph drainage [
<xref ref-type="bibr" rid="CR112">112</xref>
]. Each patient should be offered several training sessions in validated specific patient-education programs to master the wrapping procedure and verify good understanding and implementation. Overnight bandaging at least three times per week is recommended during long-term maintenance. The aim of learning self-bandaging is to improve the patient’s autonomy to manage his/her own lymphedema [
<xref ref-type="bibr" rid="CR113">113</xref>
].</p>
</sec>
<sec id="Sec24">
<title>Sinusitis</title>
<p>Treatment of acute sinusitis is based on antibiotics (amoxicillin–clavulanate (1.5–3 g/day), or, in the case of penicillin allergy, doxycycline (200 mg/day), fluoroquinolone (levofloxacin, 500 mg/day) or moxifloxacin (400 mg/day)) for 5–7 days [
<xref ref-type="bibr" rid="CR114">114</xref>
]. Treatment of chronic sinusitis is not specific for YNS patients but global responses to medications, including short-course oral antibiotics, topical intranasal steroids, saline irrigation and topical or oral decongestant, are poor [
<xref ref-type="bibr" rid="CR115">115</xref>
]. Surgical procedures may be necessary and are essentially based on endoscopic sinus surgery (endoscopic middle meatal antrostomy, conventional inferior meatal antrostomy) [
<xref ref-type="bibr" rid="CR116">116</xref>
].</p>
</sec>
</sec>
<sec id="Sec25">
<title>Prognosis</title>
<p>Spontaneous remission of the nail changes has been observed in up to 30% of the YNS patients, regardless of treatment [
<xref ref-type="bibr" rid="CR5">5</xref>
]. Remission of nail changes was more likely for fingernails than toenails, perhaps because of persistent lower limb lymphedema, which might maintain the presumed lymphatic pathophysiology [
<xref ref-type="bibr" rid="CR5">5</xref>
]. More generally, the attenuated discoloration is not associated with simultaneous regression of other systemic manifestations. In YNS associated with malignant disease, treatment of the latter may lead to attenuation or disappearance of the clinical YNS signs [
<xref ref-type="bibr" rid="CR62">62</xref>
,
<xref ref-type="bibr" rid="CR69">69</xref>
]. In Maldonado et al.’s study, 17 of the 37 patients with available follow-up information died after a median of 82 months [
<xref ref-type="bibr" rid="CR6">6</xref>
]. In that study, a Kaplan–Meier survival curve estimated median survival at 132 months, shorter than that of a paired-control population.</p>
</sec>
<sec id="Sec26">
<title>Conclusion</title>
<p>YNS is very rare disorder associating yellow nail discoloration, lung manifestations/sinusitis and lymphedema. It is more frequently isolated but may be associated with other diseases implicating the lymphatic system, autoimmune diseases or cancers. Its etiology remains unknown, although lymphatic impairment is regularly evoked in the literature. Titanium is a more recent hypothetical agent but so far remains unconfirmed to explain the syndrome. YNS treatment is symptomatic for each component: yellow nails, pulmonary manifestations/sinusitis, lymphedema. Vitamin E combined with fluconazole, usually prescribed to treat yellow nails, achieves partial or complete responses. Spontaneous resolution is also possible. Research is required to better understand and treat this rare and very poorly recognized disease.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>YNS</term>
<def>
<p>Yellow nail syndrome</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<p>Not applicable.</p>
<sec id="FPar1">
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>SV conceived, designed and wrote the review, RB wrote the review. Both authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Heller</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Die Krankheiten der Nagel</article-title>
<source>Jadassohn's Handbuch der Haut und Geschlechtskrankheiten</source>
<year>1927</year>
<publisher-loc>Berlin</publisher-loc>
<publisher-name>Julius Springer</publisher-name>
<fpage>423</fpage>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samman</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>White</surname>
<given-names>WF</given-names>
</name>
</person-group>
<article-title>The yellow nail syndrome</article-title>
<source>Br J Dermatol</source>
<year>1964</year>
<volume>76</volume>
<fpage>153</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2133.1964.tb14499.x</pub-id>
<pub-id pub-id-type="pmid">14140738</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emerson</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Yellow nails, lymphoedema, and pleural effusions</article-title>
<source>Thorax</source>
<year>1966</year>
<volume>21</volume>
<fpage>247</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1136/thx.21.3.247</pub-id>
<pub-id pub-id-type="pmid">5914998</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rosenow</surname>
<given-names>EC</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Olsen</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Pulmonary manifestations of the yellow nail syndrome</article-title>
<source>Chest</source>
<year>1972</year>
<volume>61</volume>
<fpage>452</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1378/chest.61.5.452</pub-id>
<pub-id pub-id-type="pmid">5046843</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoque</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Mansour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mortimer</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature</article-title>
<source>Br J Dermatol</source>
<year>2007</year>
<volume>156</volume>
<fpage>1230</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2133.2007.07894.x</pub-id>
<pub-id pub-id-type="pmid">17459037</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maldonado</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tazelaar</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: analysis of 41 consecutive patients</article-title>
<source>Chest</source>
<year>2008</year>
<volume>134</volume>
<fpage>375</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1378/chest.08-0137</pub-id>
<pub-id pub-id-type="pmid">18403655</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piraccini</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Urciuoli</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Starace</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tosti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Balestri</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: clinical experience in a series of 21 patients</article-title>
<source>J Dtsch Dermatol Ges</source>
<year>2014</year>
<volume>12</volume>
<fpage>131</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">24134631</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordkild</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kromann-Andersen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Struve-Christensen</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome – the triad of yellow nails, lymphoedema, and pleural effusions. A review of the literature and a case report</article-title>
<source>Acta Med Scand</source>
<year>1986</year>
<volume>219</volume>
<fpage>221</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1111/j.0954-6820.1986.tb03302.x</pub-id>
<pub-id pub-id-type="pmid">3962735</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varney</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Cumberworth</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sudderick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Durham</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>IS</given-names>
</name>
</person-group>
<article-title>Rhinitis, sinusitis and the yellow nail syndrome: a review of symptoms and response to treatment in 17 patients</article-title>
<source>Clin Otolaryngol Allied Sci</source>
<year>1994</year>
<volume>19</volume>
<fpage>237</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2273.1994.tb01222.x</pub-id>
<pub-id pub-id-type="pmid">7923847</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavlidakey</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome</article-title>
<source>J Am Acad Dermatol</source>
<year>1984</year>
<volume>11</volume>
<fpage>509</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/S0190-9622(84)70201-5</pub-id>
<pub-id pub-id-type="pmid">6384296</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Esterly</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Prendiville</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fujisaki</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The yellow nail syndrome in an 8-year-old girl</article-title>
<source>Pediatr Dermatol</source>
<year>1987</year>
<volume>4</volume>
<fpage>90</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1111/j.1525-1470.1987.tb00758.x</pub-id>
<pub-id pub-id-type="pmid">3658839</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paradisis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Asperen</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in infancy</article-title>
<source>J Paediatr Child Health</source>
<year>1997</year>
<volume>33</volume>
<fpage>454</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1754.1997.tb01642.x</pub-id>
<pub-id pub-id-type="pmid">9401896</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Göçmen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Küçükosmanoglu</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kiper</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Karaduman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ozçelik</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in 10-year-old girl</article-title>
<source>Turk J Pediatr</source>
<year>1997</year>
<volume>39</volume>
<fpage>105</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">10868201</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yalçin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dogru</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gönç</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Cetinkaya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kiper</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in an infant presenting with lymphedema of the eyelids and pleural effusion</article-title>
<source>Clin Pediatr (Phila)</source>
<year>2004</year>
<volume>43</volume>
<fpage>569</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1177/000992280404300610</pub-id>
<pub-id pub-id-type="pmid">15248011</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douri</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in two siblings</article-title>
<source>Dermatol Online J</source>
<year>2008</year>
<volume>14</volume>
<fpage>7</fpage>
<pub-id pub-id-type="pmid">19061589</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cebeci</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Celebi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Onsun</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Non classical yellow nail syndrome in 6-year-old girl: a case report</article-title>
<source>Cases J</source>
<year>2009</year>
<volume>2</volume>
<fpage>165</fpage>
<pub-id pub-id-type="doi">10.1186/1757-1626-2-165</pub-id>
<pub-id pub-id-type="pmid">19946476</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nanda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Essa</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>El-Shafei</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Alsaleh</surname>
<given-names>QA</given-names>
</name>
</person-group>
<article-title>Congenital yellow nail syndrome: a case report and its relationship to nonimmune fetal hydrops</article-title>
<source>Pediatr Dermatol</source>
<year>2010</year>
<volume>27</volume>
<fpage>533</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1525-1470.2010.01259.x</pub-id>
<pub-id pub-id-type="pmid">20807364</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddiq</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Yellow nails, lymphedema and chronic cough: yellow nail syndrome in an eight-year-old girl</article-title>
<source>Can Respir J</source>
<year>2012</year>
<volume>19</volume>
<fpage>35</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1155/2012/464879</pub-id>
<pub-id pub-id-type="pmid">22332131</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cecchini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doumit</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kanigsberg</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Atypical presentation of congenital yellow nail syndrome in a 2-year-old female</article-title>
<source>J Cutan Med Surg</source>
<year>2013</year>
<volume>17</volume>
<fpage>66</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.2310/7750.2012.12015</pub-id>
<pub-id pub-id-type="pmid">23364154</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dessart</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Deries</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guérin-Moreau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Troussier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Syndrome des ongles jaunes: deux cas pédiatriques</article-title>
<source>Ann Dermatol Venereol</source>
<year>2014</year>
<volume>141</volume>
<fpage>611</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.annder.2014.06.026</pub-id>
<pub-id pub-id-type="pmid">25288066</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Hawsawi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome</article-title>
<source>Pediatr Dermatol</source>
<year>2010</year>
<volume>27</volume>
<fpage>675</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/j.1525-1470.2010.01338.x</pub-id>
<pub-id pub-id-type="pmid">21510012</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wells</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome with familial primary hypoplasia of lymphatics, manifest late in life</article-title>
<source>Proc Royal Soc Med</source>
<year>1966</year>
<volume>59</volume>
<fpage>447</fpage>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambert</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Dziura</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kauls</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mercurio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Antaya</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in three siblings: a randomized double-blind trial of topical vitamin E</article-title>
<source>Pediatr Dermatol</source>
<year>2006</year>
<volume>23</volume>
<fpage>390</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1111/j.1525-1470.2006.00251.x</pub-id>
<pub-id pub-id-type="pmid">16918641</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Razi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Familial yellow nail syndrome</article-title>
<source>Dermatol Online J</source>
<year>2006</year>
<volume>12</volume>
<fpage>15</fpage>
<pub-id pub-id-type="pmid">16638408</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamatani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Umeyama</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Yellow nail syndrome associated with mental retardation in two siblings</article-title>
<source>Br J Dermatol</source>
<year>1978</year>
<volume>99</volume>
<fpage>329</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2133.1978.tb02005.x</pub-id>
<pub-id pub-id-type="pmid">708602</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinman</surname>
<given-names>PK</given-names>
</name>
</person-group>
<article-title>Congenital lymphedema and yellow nails</article-title>
<source>J Pediatr</source>
<year>1973</year>
<volume>83</volume>
<fpage>454</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(73)80271-9</pub-id>
<pub-id pub-id-type="pmid">4725148</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baran</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Pigmentations of the nails (chromonychia)</article-title>
<source>J Dermatol Surg Oncol</source>
<year>1978</year>
<volume>4</volume>
<fpage>250</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1524-4725.1978.tb00422.x</pub-id>
<pub-id pub-id-type="pmid">632390</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stosiek</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Riedl</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hornstein</surname>
<given-names>OP</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in a patient with mycosis fungoides</article-title>
<source>J Am Acad Dermatol</source>
<year>1993</year>
<volume>28</volume>
<fpage>792</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1016/S0190-9622(09)80277-6</pub-id>
<pub-id pub-id-type="pmid">8496432</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Holzberg</surname>
<given-names>M</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Baran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Berker</surname>
<given-names>DAR</given-names>
</name>
<name>
<surname>Holzberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The nail in systemic disease</article-title>
<source>Baran and Dawber’s diseases of the nails and their management</source>
<year>2012</year>
<edition>4</edition>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Wiley-Blackwell</publisher-name>
<fpage>328</fpage>
<lpage>30</lpage>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venencie</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Dicken</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: report of five cases</article-title>
<source>J Am Acad Dermatol</source>
<year>1984</year>
<volume>10</volume>
<fpage>187</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/S0190-9622(84)70021-1</pub-id>
<pub-id pub-id-type="pmid">6715590</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moffitt</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>de Berker</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: the nail that grows half as fast grows twice as thick</article-title>
<source>Clin Exp Dermatol</source>
<year>2000</year>
<volume>25</volume>
<fpage>21</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2230.2000.00563.x</pub-id>
<pub-id pub-id-type="pmid">10671964</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdés</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huggins</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Gude</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ferreiro</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Alvarez-Dobaño</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Golpe</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characteristics of patients with yellow nail syndrome and pleural effusion</article-title>
<source>Respirology</source>
<year>2014</year>
<volume>19</volume>
<fpage>985</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1111/resp.12357</pub-id>
<pub-id pub-id-type="pmid">25123563</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodfield</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nisbet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Loebinger</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Hansell</surname>
<given-names>DM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bronchiectasis in yellow nail syndrome</article-title>
<source>Respirology</source>
<year>2017</year>
<volume>22</volume>
<fpage>101</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1111/resp.12866</pub-id>
<pub-id pub-id-type="pmid">27551950</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sacco</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Fregonese</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Marino</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gambini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome and bilateral cystic lung disease</article-title>
<source>Pediatr Pulmonol</source>
<year>1998</year>
<volume>26</volume>
<fpage>29</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1099-0496(199812)26:6<429::AID-PPUL8>3.0.CO;2-8</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szuba</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rockson</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Lymphedema: classification, diagnosis and therapy</article-title>
<source>Vasc Med</source>
<year>1998</year>
<volume>3</volume>
<fpage>145</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1191/135886398674160447</pub-id>
<pub-id pub-id-type="pmid">9796078</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zampell</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Aschen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weitman</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elhadad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Brot</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation</article-title>
<source>Plast Reconstr Surg</source>
<year>2012</year>
<volume>129</volume>
<fpage>825</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1097/PRS.0b013e3182450b2d</pub-id>
<pub-id pub-id-type="pmid">22456354</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupuy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benchikhi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Roujeau</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vaillant</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chosidow</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk factors for erysipelas of the leg (cellulitis): case–control study</article-title>
<source>BMJ</source>
<year>1999</year>
<volume>318</volume>
<fpage>1591</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.318.7198.1591</pub-id>
<pub-id pub-id-type="pmid">10364117</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okajima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tamai</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Health-related quality of life and associated factors in patients with primary lymphedema</article-title>
<source>Jpn J Nurs Sci</source>
<year>2013</year>
<volume>10</volume>
<fpage>202</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1111/j.1742-7924.2012.00220.x</pub-id>
<pub-id pub-id-type="pmid">24373443</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maisels</surname>
<given-names>DO</given-names>
</name>
<name>
<surname>Korachi</surname>
<given-names>AO</given-names>
</name>
</person-group>
<article-title>Lymphoedema of the eyelids in the yellow nail syndrome</article-title>
<source>Br J Plast Surg</source>
<year>1985</year>
<volume>38</volume>
<fpage>93</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/0007-1226(85)90093-1</pub-id>
<pub-id pub-id-type="pmid">3881152</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourcier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Baudrimont</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Borderie</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mayaud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Laroche</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Conjunctival changes associated with yellow nail syndrome</article-title>
<source>Br J Ophthalmol</source>
<year>2002</year>
<volume>86</volume>
<fpage>930</fpage>
<pub-id pub-id-type="doi">10.1136/bjo.86.8.930</pub-id>
<pub-id pub-id-type="pmid">12140219</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marks</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Yellow nails: a report of six cases</article-title>
<source>Arch Dermatol</source>
<year>1970</year>
<volume>102</volume>
<fpage>619</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1001/archderm.1970.04000120037006</pub-id>
<pub-id pub-id-type="pmid">5501903</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bull</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Fenton</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Mortimer</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Lymphatic function in the yellow nail syndrome</article-title>
<source>Br J Dermatol</source>
<year>1996</year>
<volume>134</volume>
<fpage>307</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2133.1996.tb07619.x</pub-id>
<pub-id pub-id-type="pmid">8746347</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maldonado</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome</article-title>
<source>Curr Opin Pulm Med</source>
<year>2009</year>
<volume>15</volume>
<fpage>371</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1097/MCP.0b013e32832ad45a</pub-id>
<pub-id pub-id-type="pmid">19373089</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Alessandro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Muzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Filiberto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barboni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abbritti</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: does protein leakage play a role?</article-title>
<source>Eur Respir J</source>
<year>2001</year>
<volume>17</volume>
<fpage>149</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1183/09031936.01.17101490</pub-id>
<pub-id pub-id-type="pmid">11307745</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeCoste</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Imber</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Baden</surname>
<given-names>HP</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome</article-title>
<source>J Am Acad Dermatol</source>
<year>1990</year>
<volume>22</volume>
<fpage>608</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1016/0190-9622(90)70081-R</pub-id>
<pub-id pub-id-type="pmid">2319021</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solal-Céligny</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cormier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fournier</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The yellow nail syndrome. Light and electron microscopic aspects of the pleura</article-title>
<source>Arch Pathol Lab Med</source>
<year>1983</year>
<volume>107</volume>
<fpage>183</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">6687537</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Echevarria</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bourke</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Case-based discussion from North Tyneside General Hospital: somatostatin analogues in yellow nail syndrome associated with recurrent pleural effusions</article-title>
<source>Thorax</source>
<year>2014</year>
<volume>69</volume>
<fpage>967</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1136/thoraxjnl-2014-205426</pub-id>
<pub-id pub-id-type="pmid">24923874</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norton</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Further observations on the yellow nail syndrome with therapeutic effects of oral alpha-tocopherol</article-title>
<source>Cutis</source>
<year>1985</year>
<volume>36</volume>
<fpage>457</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">4075838</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berglund</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Carlmark</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Titanium, sinusitis, and the yellow nail syndrome</article-title>
<source>Biol Trace Elem Res</source>
<year>2011</year>
<volume>143</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-010-8828-5</pub-id>
<pub-id pub-id-type="pmid">20809268</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Decker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Scher</surname>
<given-names>RK</given-names>
</name>
</person-group>
<article-title>Role of titanium in the development of yellow nail syndrome</article-title>
<source>Skin Appendage Disord</source>
<year>2015</year>
<volume>1</volume>
<fpage>28</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1159/000375171</pub-id>
<pub-id pub-id-type="pmid">27172293</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ataya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kline</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Cope</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alnuaimat</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Titanium exposure and yellow nail syndrome</article-title>
<source>Respir Med Case Rep</source>
<year>2015</year>
<volume>16</volume>
<fpage>146</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">26744684</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Titanium dioxide in toothpaste causing yellow nail syndrome</article-title>
<source>Pediatrics</source>
<year>2017</year>
<volume>139</volume>
<fpage>e20160546</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2016-0546</pub-id>
<pub-id pub-id-type="pmid">27940507</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dos Santos</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Titanium pigment and yellow nail syndrome</article-title>
<source>Skin Appendage Disord</source>
<year>2016</year>
<volume>1</volume>
<fpage>197</fpage>
<pub-id pub-id-type="doi">10.1159/000445722</pub-id>
<pub-id pub-id-type="pmid">27386465</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dickinson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Halbert</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome presenting as non immune hydrops: second case report</article-title>
<source>Am J Med Genet</source>
<year>2000</year>
<volume>93</volume>
<fpage>1</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(20000703)93:1<1::AID-AJMG1>3.0.CO;2-4</pub-id>
<pub-id pub-id-type="pmid">10861674</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govaert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leroy</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Pauwels</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vanhaesebrouck</surname>
<given-names>P</given-names>
</name>
<name>
<surname>De Praeter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van Kets</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perinatal manifestations of maternal yellow nail syndrome</article-title>
<source>Pediatrics</source>
<year>1992</year>
<volume>89</volume>
<fpage>1016</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">1594340</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desramé</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Béchade</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Patte</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Jean</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Karsenti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Coutant</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Syndrome des ongles jaunes associé à des lymphangiectasies intestinales</article-title>
<source>Gastroenterol Clin Biol</source>
<year>2000</year>
<volume>24</volume>
<fpage>837</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">11011259</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duhra</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>MN</given-names>
</name>
</person-group>
<article-title>Chylous ascites, intestinal lymphangiectasia and the ‘yellow-nail’ syndrome</article-title>
<source>Gut</source>
<year>1985</year>
<volume>26</volume>
<fpage>1266</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1136/gut.26.11.1266</pub-id>
<pub-id pub-id-type="pmid">4065700</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vignes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bellanger</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Primary intestinal lymphangiectasia (Waldmann’s disease)</article-title>
<source>Orphanet J Rare Dis</source>
<year>2008</year>
<volume>3</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1172-3-5</pub-id>
<pub-id pub-id-type="pmid">18294365</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brice</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mansour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Collin</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Child</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>AF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the phenotypic abnormalities in lymphoedema–distichiasis syndrome in 74 patients with
<italic>FOXC2</italic>
mutations or linkage to 16q24</article-title>
<source>J Med Genet</source>
<year>2002</year>
<volume>39</volume>
<fpage>478</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.39.7.478</pub-id>
<pub-id pub-id-type="pmid">12114478</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Sidhu</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome and bronchial carcinoma</article-title>
<source>Chest</source>
<year>1987</year>
<volume>92</volume>
<fpage>191</fpage>
<pub-id pub-id-type="doi">10.1378/chest.92.1.191a</pub-id>
<pub-id pub-id-type="pmid">3595241</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carnassale</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Margaritora</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vita</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Mariantonia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Congedo</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Cusumano</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lung cancer in association with yellow nail syndrome</article-title>
<source>J Clin Oncol</source>
<year>2011</year>
<volume>29</volume>
<fpage>e156</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1200/JCO.2010.31.8402</pub-id>
<pub-id pub-id-type="pmid">21149669</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rossoff</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Marzouk</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>HN</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: resolution of yellow nails after successful treatment of breast cancer</article-title>
<source>Chest</source>
<year>2000</year>
<volume>117</volume>
<fpage>1516</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1378/chest.117.5.1516</pub-id>
<pub-id pub-id-type="pmid">10807848</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Haberman</surname>
<given-names>HF</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome</article-title>
<source>Cutis</source>
<year>1986</year>
<volume>37</volume>
<fpage>371</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">3011360</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginarte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monteagudo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Toribio</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome and lung lymphoma</article-title>
<source>Clin Exp Dermatol</source>
<year>2004</year>
<volume>29</volume>
<fpage>432</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2230.2004.01541.x</pub-id>
<pub-id pub-id-type="pmid">15245553</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sève</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thieblemont</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dumontet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bouafia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arnaud</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hequet</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Skin lesions in malignancy. Case 3. Yellow nail syndrome in non-Hodgkin’s lymphoma</article-title>
<source>J Clin Oncol</source>
<year>2001</year>
<volume>19</volume>
<fpage>2100</fpage>
<lpage>1</lpage>
<pub-id pub-id-type="doi">10.1200/JCO.2001.19.7.2100</pub-id>
<pub-id pub-id-type="pmid">11283146</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burrows</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>RR</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in association with carcinoma of the gall bladder</article-title>
<source>Clin Exp Dermatol</source>
<year>1991</year>
<volume>16</volume>
<fpage>471</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2230.1991.tb01240.x</pub-id>
<pub-id pub-id-type="pmid">1806327</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guin</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Elleman</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome. Possible association with malignancy</article-title>
<source>Arch Dermatol</source>
<year>1979</year>
<volume>115</volume>
<fpage>734</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1001/archderm.1979.04010060042027</pub-id>
<pub-id pub-id-type="pmid">453878</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mambretti-Zumwalt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seidman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Higano</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: complete triad with pleural protein turnover studies</article-title>
<source>South Med J</source>
<year>1980</year>
<volume>73</volume>
<fpage>995</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1097/00007611-198008000-00013</pub-id>
<pub-id pub-id-type="pmid">7403938</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grégoire</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guiot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vertenoeil</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hafraoui</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Corhay</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Yellow nail syndrome after allogeneic hematopoietic stem cell transplantation in two patients with multiple myeloma</article-title>
<source>Acta Clin Belg</source>
<year>2016</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Samra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>T and B cell deficiency associated with yellow nail syndrome</article-title>
<source>Scand J Immunol</source>
<year>2012</year>
<volume>75</volume>
<fpage>329</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-3083.2011.02653.x</pub-id>
<pub-id pub-id-type="pmid">21995335</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegelman</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Heckman</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Hasson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Lymphedema, pleural effusions and yellow nails: associated immunologic deficiency</article-title>
<source>Dis Chest</source>
<year>1969</year>
<volume>56</volume>
<fpage>114</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1378/chest.56.2.114</pub-id>
<pub-id pub-id-type="pmid">5822545</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woollons</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Darley</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome following Guillain–Barré syndrome</article-title>
<source>Clin Exp Dermatol</source>
<year>1997</year>
<volume>22</volume>
<fpage>253</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2230.1997.tb01084.x</pub-id>
<pub-id pub-id-type="pmid">9536552</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cockram</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Yellow nails and nephrotic syndrome</article-title>
<source>Br J Dermatol</source>
<year>1979</year>
<volume>101</volume>
<fpage>707</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2133.1979.tb05651.x</pub-id>
<pub-id pub-id-type="pmid">534618</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Funakoshi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Case of yellow nail syndrome accompanied by nephrotic syndrome</article-title>
<source>J Dermatol</source>
<year>2016</year>
<volume>43</volume>
<fpage>585</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/1346-8138.13239</pub-id>
<pub-id pub-id-type="pmid">26704457</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dilley</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kierland</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Shick</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Primary lymphedema associated with yellow nails and pleural effusions</article-title>
<source>JAMA</source>
<year>1968</year>
<volume>204</volume>
<fpage>670</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1001/jama.1968.03140210024005</pub-id>
<pub-id pub-id-type="pmid">5694508</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noël-Savina</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Paleiron</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Leroyer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Descourt</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Découverte d’un syndrome des ongles jaunes lors d’une insuffisance thyroïdienne majeure</article-title>
<source>Rev Pneumol Clin</source>
<year>2012</year>
<volume>68</volume>
<fpage>315</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneumo.2012.06.001</pub-id>
<pub-id pub-id-type="pmid">22884167</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakielna</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ballon</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title>Yellow-nail syndrome: report of three cases</article-title>
<source>Can Med Assoc J</source>
<year>1976</year>
<volume>115</volume>
<fpage>46</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">1277061</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danenberg</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Eliashar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Flusser</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rosenmann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chajek-Shaul</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome and xanthogranulomatous pyelonephritis</article-title>
<source>Postgrad Med J</source>
<year>1995</year>
<volume>71</volume>
<fpage>110</fpage>
<lpage>1</lpage>
<pub-id pub-id-type="doi">10.1136/pgmj.71.832.110</pub-id>
<pub-id pub-id-type="pmid">7724421</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>David-Vaudey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jamard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hermant</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cantagrel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in rheumatoid arthritis: a drug-induced disease?</article-title>
<source>Clin Rheumatol</source>
<year>2004</year>
<volume>23</volume>
<fpage>376</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1007/s10067-004-0862-2</pub-id>
<pub-id pub-id-type="pmid">15293107</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Runyon</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Forker</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Sopko</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Pleural-fluid kinetics in a patient with primary lymphedema, pleural effusions, and yellow nails</article-title>
<source>Am Rev Respir Dis</source>
<year>1979</year>
<volume>119</volume>
<fpage>821</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">453703</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bokszczanin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levinson</surname>
<given-names>AI</given-names>
</name>
</person-group>
<article-title>Coexistent yellow nail syndrome and selective antibody deficiency</article-title>
<source>Ann Allergy Asthma Immunol</source>
<year>2003</year>
<volume>91</volume>
<fpage>496</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="doi">10.1016/S1081-1206(10)61521-9</pub-id>
<pub-id pub-id-type="pmid">14692436</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vignes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carcelain</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Increased surface receptor Fas (CD95) levels on CD4
<sup>+</sup>
lymphocytes in patients with primary intestinal lymphangiectasia</article-title>
<source>Scand J Gastroenterol</source>
<year>2009</year>
<volume>44</volume>
<fpage>252</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1080/00365520802321220</pub-id>
<pub-id pub-id-type="pmid">18855225</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattingly</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Bossingham</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in rheumatoid arthritis: report of three cases</article-title>
<source>Ann Rheum Dis</source>
<year>1979</year>
<volume>38</volume>
<fpage>475</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1136/ard.38.5.475</pub-id>
<pub-id pub-id-type="pmid">518148</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakagomi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases</article-title>
<source>Rheumatol Int</source>
<year>2013</year>
<volume>33</volume>
<fpage>793</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s00296-011-2241-z</pub-id>
<pub-id pub-id-type="pmid">22090009</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>George</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>George</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome in rheumatoid arthritis: an aetiology beyond thiol drugs</article-title>
<source>Oxf Med Case Rep</source>
<year>2016</year>
<volume>2016</volume>
<fpage>37</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1093/omcr/omw013</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiriac</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brzezinski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Foia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marincu</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Chloronychia: green nail syndrome caused by
<italic>Pseudomonas aeruginosa</italic>
in elderly persons</article-title>
<source>Clin Interv Aging</source>
<year>2015</year>
<volume>10</volume>
<fpage>265</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.2147/CIA.S75525</pub-id>
<pub-id pub-id-type="pmid">25609938</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haneke</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Isolated bullous lichen planus of the nails mimicking yellow nail syndrome</article-title>
<source>Clin Exp Dermatol</source>
<year>1983</year>
<volume>8</volume>
<fpage>425</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2230.1983.tb01806.x</pub-id>
<pub-id pub-id-type="pmid">6627735</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baran</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Lichen planus of the nails mimicking the yellow nail syndrome</article-title>
<source>Br J Dermatol</source>
<year>2000</year>
<volume>143</volume>
<fpage>1117</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2133.2000.03811.x</pub-id>
<pub-id pub-id-type="pmid">11069547</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Piraccini</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Cameli</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Nail changes in lichen planus may resemble those of yellow nail syndrome</article-title>
<source>Br J Dermatol</source>
<year>2000</year>
<volume>142</volume>
<fpage>848</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2133.2000.03460.x</pub-id>
<pub-id pub-id-type="pmid">10792266</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Baran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rycroft</surname>
<given-names>RJG</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Baran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Berker</surname>
<given-names>DAR</given-names>
</name>
<name>
<surname>Holzberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Occupational abnormalities and contact dermatitis</article-title>
<source>Baran and Dawber’s diseases of the nails and their management</source>
<year>2012</year>
<edition>4</edition>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Wiley-Blackwell</publisher-name>
<fpage>443</fpage>
<lpage>69</lpage>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiyad</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cousins</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mortimer</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: a primary lymphatic disorder?</article-title>
<source>Br J Dermatol</source>
<year>2014</year>
<volume>171</volume>
<issue>Suppl 1</issue>
<fpage>9</fpage>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Samman</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome treated by intra-lesional triamcinolone acetonide</article-title>
<source>Br J Dermatol</source>
<year>1973</year>
<volume>88</volume>
<fpage>200</fpage>
<lpage>1</lpage>
<pub-id pub-id-type="pmid">4706464</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayres</surname>
<given-names>S</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Mihan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: response to vitamin E</article-title>
<source>Arch Dermatol</source>
<year>1973</year>
<volume>108</volume>
<fpage>267</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1001/archderm.1973.01620230063024</pub-id>
<pub-id pub-id-type="pmid">4724132</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Buffham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>du Vivier</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome</article-title>
<source>Arch Dermatol</source>
<year>1991</year>
<volume>127</volume>
<fpage>1023</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1001/archderm.1991.01680060097012</pub-id>
<pub-id pub-id-type="pmid">2064401</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arroyo</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Improvement of yellow nail syndrome with oral zinc supplementation</article-title>
<source>Clin Exp Dermatol</source>
<year>1993</year>
<volume>18</volume>
<fpage>62</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2230.1993.tb00971.x</pub-id>
<pub-id pub-id-type="pmid">8440057</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Piraccini</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Iorizzo</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Systemic itraconazole in the yellow nail syndrome</article-title>
<source>Br J Dermatol</source>
<year>2002</year>
<volume>146</volume>
<fpage>1064</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2133.2002.04671.x</pub-id>
<pub-id pub-id-type="pmid">12072079</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome</article-title>
<source>J Drugs Dermatol</source>
<year>2009</year>
<volume>8</volume>
<fpage>276</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">19271377</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doncker</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Pierard</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>Acquired nail beading in patients receiving itraconazole – an indicator of faster nail growth? A study using optical profilometry</article-title>
<source>Clin Exp Dermatol</source>
<year>1994</year>
<volume>19</volume>
<fpage>404</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2230.1994.tb02693.x</pub-id>
<pub-id pub-id-type="pmid">7955498</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luyten</surname>
<given-names>C</given-names>
</name>
<name>
<surname>André</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Walraevens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Doncker</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E</article-title>
<source>Dermatology</source>
<year>1996</year>
<volume>192</volume>
<fpage>406</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1159/000246433</pub-id>
<pub-id pub-id-type="pmid">8864394</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoshizawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ichimura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takasaki</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A case of yellow nail syndrome with dramatically improved nail discoloration by oral clarithromycin</article-title>
<source>Case Rep Dermatol</source>
<year>2011</year>
<volume>3</volume>
<fpage>251</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1159/000334734</pub-id>
<pub-id pub-id-type="pmid">22220146</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imadojemu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Dramatic improvement of yellow nail syndrome with a combination of intralesional triamcinolone, fluconazole, and sinusitis management</article-title>
<source>Int J Dermatol</source>
<year>2015</year>
<volume>54</volume>
<fpage>e497</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/ijd.12916</pub-id>
<pub-id pub-id-type="pmid">26226835</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balmforth</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bille</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okiror</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Harrsion-Phipps</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Routledge</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Recurrent pleural effusion in yellow nail syndrome successfully treated with video-assisted thoracic surgery: comparison of two surgical strategies in two cases</article-title>
<source>Gen Thorac Cardiovasc Surg</source>
<year>2013</year>
<volume>61</volume>
<fpage>231</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1007/s11748-012-0125-0</pub-id>
<pub-id pub-id-type="pmid">22763641</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamagishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hatanaka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kamemura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kodaka</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Idiopathic yellow nail syndrome successfully treated with OK-432</article-title>
<source>Intern Med</source>
<year>2007</year>
<volume>46</volume>
<fpage>1127</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.2169/internalmedicine.46.0022</pub-id>
<pub-id pub-id-type="pmid">17634713</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Widjaja</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gratz</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Ockenga</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Manns</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Octreotide for therapy of chylous ascites in yellow nail syndrome</article-title>
<source>Gastroenterology</source>
<year>1999</year>
<volume>116</volume>
<fpage>1017</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/S0016-5085(99)70097-1</pub-id>
<pub-id pub-id-type="pmid">10092335</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makrilakis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pavlatos</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giannikopoulos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Toubanakis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Katsilambros</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Successful octreotide treatment of chylous pleural effusion and lymphedema in the yellow nail syndrome</article-title>
<source>Ann Intern Med</source>
<year>2004</year>
<volume>141</volume>
<fpage>246</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.7326/0003-4819-141-3-200408030-00028</pub-id>
<pub-id pub-id-type="pmid">15289232</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lotfollahi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Abedini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alavi Darazam</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kiani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fadaii</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: report of a case successfully treated with octreotide</article-title>
<source>Tanaffos</source>
<year>2015</year>
<volume>14</volume>
<fpage>67</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">26221155</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hillerdal</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Yellow nail syndrome: treatment with octreotide</article-title>
<source>Clin Respir J</source>
<year>2007</year>
<volume>1</volume>
<fpage>120</fpage>
<lpage>1</lpage>
<pub-id pub-id-type="doi">10.1111/j.1752-699X.2007.00022.x</pub-id>
<pub-id pub-id-type="pmid">20298292</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakabayashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sagara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Usukura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yoshimitsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Seta</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs</article-title>
<source>Diabetes</source>
<year>1981</year>
<volume>30</volume>
<fpage>440</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.2337/diab.30.5.440</pub-id>
<pub-id pub-id-type="pmid">6112179</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahid</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Marbach</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Stolz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>James</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Partial tachyphylaxis to somatostatin (SST) analogues in a patient with acromegaly: the role of SST receptor desensitisation and circulating antibodies to SST analogues</article-title>
<source>Eur J Endocrinol</source>
<year>2002</year>
<volume>146</volume>
<fpage>295</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1530/eje.0.1460295</pub-id>
<pub-id pub-id-type="pmid">11888834</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheville</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>McGarvey</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Petrek</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Thiadens</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Lymphedema management</article-title>
<source>Semin Radiat Oncol</source>
<year>2003</year>
<volume>13</volume>
<fpage>290</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="doi">10.1016/S1053-4296(03)00035-3</pub-id>
<pub-id pub-id-type="pmid">12903017</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasinski</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>McKillip Thrift</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Squire</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wanchai</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011</article-title>
<source>PM R</source>
<year>2012</year>
<volume>4</volume>
<fpage>580</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.1016/j.pmrj.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">22920313</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>International Society of Lymphology</collab>
</person-group>
<article-title>The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the International Society of Lymphology</article-title>
<source>Lymphology</source>
<year>2013</year>
<volume>46</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">23930436</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Vignes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arrault</surname>
<given-names>M</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Simon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Traynard</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Bourdillon</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gagnayre</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Grimaldi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Prise en charge des patients atteints de lymphœdème</article-title>
<source>Education Thérapeutique</source>
<year>2013</year>
<publisher-loc>Paris</publisher-loc>
<publisher-name>Elsevier Masson</publisher-name>
<fpage>261</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeCastro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mims</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hueston</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Rhinosinusitis</article-title>
<source>Prim Care</source>
<year>2014</year>
<volume>41</volume>
<fpage>47</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1016/j.pop.2013.10.006</pub-id>
<pub-id pub-id-type="pmid">24439880</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudmik</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Soler</surname>
<given-names>ZM</given-names>
</name>
</person-group>
<article-title>Medical therapies for adult chronic sinusitis: a systematic review</article-title>
<source>JAMA</source>
<year>2015</year>
<volume>314</volume>
<fpage>926</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2015.7544</pub-id>
<pub-id pub-id-type="pmid">26325561</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khalil</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Nunez</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Functional endoscopic sinus surgery for chronic rhinosinusitis</article-title>
<source>Cochrane Database Syst Rev</source>
<year>2006</year>
<volume>3</volume>
<fpage>CD004458</fpage>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F64 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000F64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:5327582
   |texte=   Yellow nail syndrome: a review
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:28241848" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024